ZNF407-Related Neurodevelopmental Disorder

Mendelian MONDO:0859198 Pathograph 39 Show in embeddings browser Neurodevelopmental disorder Autosomal recessive disease

ZNF407-related neurodevelopmental disorder is a rare autosomal recessive condition caused by biallelic damaging variants in ZNF407 (18q23), which encodes a large Kruppel-type C2H2 zinc-finger protein. Transcriptional impairment is predicted from structural modeling of one disease allele, and cofactor activity has been demonstrated only in mouse adipocytes. Complete loss of function has not been demonstrated for the reported biallelic missense and in-frame variants. OMIM/MONDO name the entity after its core clinical features: short stature, impaired intellectual development (intellectual disability), microcephaly, hypotonia, and ocular anomalies. Intellectual disability (mild to profound) is the obligate feature; short stature, microcephaly, developmental delay, hypotonia, dysarthria, hearing loss, visual problems, behavioural anomalies, delayed puberty and facial dysmorphism are variable. ZNF407 was first implicated in non-syndromic intellectual disability with autism through a balanced translocation disrupting the gene and heterozygous linker-region missense variants predicted to impair zinc-finger function; those observations do not establish the same recessive syndrome. The recessive syndromic entity was delineated in a consanguineous Arab family homozygous for the p.S1685W linker variant (2014), then expanded allelically and phenotypically in additional families with biallelic variants (2020).

Ask OpenScientist

Ask a research question about ZNF407-Related Neurodevelopmental Disorder. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Inheritance
3
Pathophys.
35
Phenotypes
1
Hypotheses
2
Gaps
39
Pathograph
1
Genes
4
References
1
Deep Research
👪

Inheritance

1
Autosomal recessive HP:0000007
Biallelic (homozygous or compound heterozygous) ZNF407 variants segregate with the phenotype in reported consanguineous and non-consanguineous families.
Autosomal recessive inheritance
Show evidence (2 references)
PMID:32737394 SUPPORT Human Clinical
"by exome sequencing identified homozygous ZNF407 c.2814_2816dup (p.Val939dup) in four affected members"
Homozygous ZNF407 variant identified in multiple affected members of a consanguineous family, consistent with autosomal recessive inheritance.
PMID:24907849 SUPPORT Human Clinical
"A consanguineous Arab family is affected by an apparently novel autosomal recessive disorder characterized by cognitive impairment, failure-to-thrive, hypotonia and dysmorphic features"
Foundational report delineating the autosomal recessive ZNF407 disorder in an independent consanguineous family.
◈

Mechanistic Hypotheses

1
ZNF407 transcriptional-dysregulation model
znf407_transcriptional_dysregulation EMERGING
Evidence balance 2 support
The current disease model proposes that biallelic damaging variants impair ZNF407 zinc-finger or cofactor function, altering transcription during fetal brain development and thereby causing the neurodevelopmental phenotype. Disease-specific support is limited to segregation and computational structural modeling of p.S1685W; no patient-derived neural assay has shown altered DNA occupancy, target-gene expression, or rescue. A 2024 study directly demonstrated ZFP407 cofactor activity in mouse adipocytes, but did not test human neurodevelopment or any disease allele.
Pathograph links
Predicted Impairment of ZNF407 Transcriptional-Regulatory Function -> Impaired Neurodevelopment INDIRECT UNKNOWN INTERMEDIATES
Predicted Impairment of ZNF407 Transcriptional-Regulatory Function -> Impaired Somatic Development INDIRECT UNKNOWN INTERMEDIATES
Impaired Neurodevelopment -> Intellectual disability INDIRECT UNKNOWN INTERMEDIATES
Impaired Neurodevelopment -> Global developmental delay INDIRECT UNKNOWN INTERMEDIATES
Impaired Neurodevelopment -> Motor delay INDIRECT UNKNOWN INTERMEDIATES
Impaired Neurodevelopment -> Delayed speech and language development INDIRECT UNKNOWN INTERMEDIATES
Impaired Neurodevelopment -> Microcephaly INDIRECT UNKNOWN INTERMEDIATES
Impaired Neurodevelopment -> Hypotonia INDIRECT UNKNOWN INTERMEDIATES
Impaired Neurodevelopment -> Gait disturbance INDIRECT UNKNOWN INTERMEDIATES Awkward, bent-knee gait acquired only at 4-5 years is part of the motor impairment modeled on the hypothesized neurodevelopmental branch; no intermediate mechanism is established.
Impaired Neurodevelopment -> Hyperreflexia INDIRECT UNKNOWN INTERMEDIATES Exaggerated deep tendon reflexes alongside hypotonia are a central nervous system sign, modeled as an endpoint of the hypothesized neurodevelopmental branch; brain MRI was structurally normal in the founding family, so no anatomic intermediate is established.
Impaired Neurodevelopment -> Dysarthria INDIRECT UNKNOWN INTERMEDIATES Dysarthria is a speech-motor endpoint reported among the cohort's variable features, modeled on the hypothesized neurodevelopmental branch.
Impaired Neurodevelopment -> Atypical behavior INDIRECT UNKNOWN INTERMEDIATES Behavioural anomalies reported in the biallelic cohort are modeled as an endpoint of the hypothesized neurodevelopmental branch.
Impaired Neurodevelopment -> Enuresis INDIRECT UNKNOWN INTERMEDIATES Enuresis, with both founding-family brothers not toilet trained at ages 11 and 5, is modeled as delayed continence acquisition within the hypothesized neurodevelopmental branch.
Impaired Neurodevelopment -> Encopresis INDIRECT UNKNOWN INTERMEDIATES Encopresis reported among the cohort's variable features is modeled as delayed continence acquisition within the hypothesized neurodevelopmental branch.
Impaired Somatic Development -> Short stature INDIRECT UNKNOWN INTERMEDIATES
Impaired Somatic Development -> Facial dysmorphism INDIRECT UNKNOWN INTERMEDIATES
Impaired Somatic Development -> Ocular anomalies INDIRECT UNKNOWN INTERMEDIATES
Impaired Somatic Development -> Hip subluxation INDIRECT UNKNOWN INTERMEDIATES
Impaired Somatic Development -> Acetabular dysplasia INDIRECT UNKNOWN INTERMEDIATES
Impaired Somatic Development -> Failure to thrive INDIRECT UNKNOWN INTERMEDIATES Failure to thrive, with height and weight at or below the 3rd centile in both founding-family brothers, is a growth endpoint of the hypothesized somatic developmental branch.
Impaired Somatic Development -> Delayed puberty INDIRECT UNKNOWN INTERMEDIATES Delayed pubertal onset is a growth and endocrine endpoint reported among the cohort's variable features, modeled on the hypothesized somatic developmental branch.
Impaired Somatic Development -> Strabismus INDIRECT UNKNOWN INTERMEDIATES Strabismus, documented on physical examination in both founding-family brothers, is an ocular endpoint of the hypothesized somatic developmental branch.
Impaired Somatic Development -> Hearing impairment INDIRECT UNKNOWN INTERMEDIATES Deafness of unspecified type is reported among the cohort's variable features; auditory evoked potentials were normal in the founding family, so this is a variable sensory endpoint of the hypothesized somatic developmental branch.
Impaired Somatic Development -> Bilateral ptosis INDIRECT UNKNOWN INTERMEDIATES Craniofacial dysmorphic endpoint documented in both founding-family brothers; modeled on the hypothesized somatic developmental branch alongside the generic facial-dysmorphism edge.
Impaired Somatic Development -> Epicanthus INDIRECT UNKNOWN INTERMEDIATES Craniofacial dysmorphic endpoint documented in the founding family; modeled on the hypothesized somatic developmental branch.
Impaired Somatic Development -> Synophrys INDIRECT UNKNOWN INTERMEDIATES Craniofacial dysmorphic endpoint documented in the founding family but explicitly absent in the later cohort; modeled on the hypothesized somatic developmental branch.
Impaired Somatic Development -> Midface hypoplasia INDIRECT UNKNOWN INTERMEDIATES Craniofacial dysmorphic endpoint documented in the founding family but explicitly absent in the later cohort; modeled on the hypothesized somatic developmental branch.
Impaired Somatic Development -> Downturned corners of the mouth INDIRECT UNKNOWN INTERMEDIATES Craniofacial dysmorphic endpoint documented in the founding family; modeled on the hypothesized somatic developmental branch.
Impaired Somatic Development -> Thin upper lip vermilion INDIRECT UNKNOWN INTERMEDIATES Craniofacial dysmorphic endpoint documented in the founding family; modeled on the hypothesized somatic developmental branch.
Impaired Somatic Development -> Protruding ears INDIRECT UNKNOWN INTERMEDIATES Craniofacial dysmorphic endpoint documented in the founding family; modeled on the hypothesized somatic developmental branch.
Impaired Somatic Development -> Camptodactyly of the fifth finger INDIRECT UNKNOWN INTERMEDIATES Musculoskeletal endpoint documented in the founding family but explicitly absent in the later cohort; modeled on the hypothesized somatic developmental branch.
Impaired Somatic Development -> Short 4th metatarsal INDIRECT UNKNOWN INTERMEDIATES Musculoskeletal endpoint documented in the founding family but explicitly absent in the later cohort; modeled on the hypothesized somatic developmental branch.
Impaired Somatic Development -> Overlapping toes INDIRECT UNKNOWN INTERMEDIATES Musculoskeletal endpoint documented in the founding family; modeled on the hypothesized somatic developmental branch.
Impaired Somatic Development -> Prominent fingertip pads INDIRECT UNKNOWN INTERMEDIATES Persistent fetal pads on fingers and toes are a limb endpoint documented in the founding family; modeled on the hypothesized somatic developmental branch.
Impaired Somatic Development -> Proximal placement of thumb INDIRECT UNKNOWN INTERMEDIATES Bilateral proximal insertion of the thumbs is a limb endpoint documented in the founding family; modeled on the hypothesized somatic developmental branch.
Impaired Somatic Development -> Kyphosis INDIRECT UNKNOWN INTERMEDIATES Mild kyphosis on skeletal survey in the founding family, explicitly absent in the later cohort; modeled on the hypothesized somatic developmental branch.
Impaired Somatic Development -> Limited knee mobility INDIRECT UNKNOWN INTERMEDIATES Musculoskeletal endpoint documented in the founding family but explicitly absent in the later cohort; modeled on the hypothesized somatic developmental branch.
Show evidence (2 references)
PMID:24907849 SUPPORT Computational
"Structural analyses of this mutation shows disruption of an H-bond"
Structural modeling supports impaired zinc-finger geometry but does not directly demonstrate altered transcription in patient neural cells.
PMID:38781157 SUPPORT In Vitro
"ZFP407 was found to interact with the PPARγ/RXRα protein complex in the nucleus of adipocytes"
Establishes transcriptional-cofactor activity in an adipocyte system, but only indirectly informs the neurodevelopmental disease mechanism.
?

Discussions and Knowledge Gaps

2
Does impaired ZNF407 zinc-finger or cofactor activity alter a specific transcriptional program in human neural development, and do the reported biallelic variants act through the same mechanism?
HUMAN MODEL MISMATCH OPEN znf407_neural_mechanism_translation
Attached to
pathophysiology#Predicted Impairment of ZNF407 Transcriptional-Regulatory Function pathophysiology#Impaired Neurodevelopment pathophysiology#Impaired Somatic Development
Disease-specific functional evidence is computational structural modeling of one missense allele. The direct experimental evidence for ZFP407 cofactor activity comes from mouse adipocytes and does not test neural cells, human development, or patient alleles. The reported recessive alleles also span missense and in-frame changes, so a uniform complete-loss-of-function model cannot be assumed. Resolving the relevant partners, targets, cell types, and allelic effects is necessary before the proposed transcriptional chain can be treated as established.
Proposed experiments
Patient-derived neural isogenic allelic series
znf407_patient_neural_isogenic_series
Compare patient-derived iPSC neural progenitors and neurons with CRISPR-corrected controls, and engineer representative reported alleles in a shared background. Measure ZNF407 abundance and localization, chromatin occupancy, protein partners, transcriptomic effects, neuronal maturation, and rescue after correction or wild-type complementation.
Readouts
Allele-specific ZNF407 molecular and neurodevelopmental phenotypes with rescue
pathophysiology#Predicted Impairment of ZNF407 Transcriptional-Regulatory Function
Show evidence (2 references)
PMID:24907849 SUPPORT Computational
"The mutated gene product was studied by structural bioinformatics methods."
The founding disease-specific functional analysis was computational rather than an assay in patient-derived neural cells.
PMID:38781157 SUPPORT In Vitro
"ZFP407 was found to interact with the PPARγ/RXRα protein complex in the nucleus of adipocytes"
The experimental cofactor evidence comes from adipocytes and therefore directly supports the stated human-neural translation gap.
What are the unbiased phenotype frequencies, developmental trajectories, adult outcomes, and genotype-phenotype relationships of biallelic ZNF407 disorder?
KNOWLEDGE GAP OPEN znf407_natural_history_and_frequency
Attached to
phenotypes#Intellectual disability phenotypes#Short stature phenotypes#Microcephaly
The core literature contains only nine affected individuals from four families. Most detailed physical findings come from two brothers, while the later abstract reports a heterogeneous seven-person expansion. This is too small and ascertainment-dependent to establish penetrance for variable findings, long-term progression, adult prognosis, or robust allelic correlations.
Proposed experiments
Genotype-first longitudinal natural-history cohort
znf407_international_natural_history_registry
Assemble an international, genotype-first cohort with harmonized HPO phenotyping, developmental assessments, growth and pubertal trajectories, ophthalmologic and audiologic evaluations, and longitudinal follow-up.
Readouts
Age-stratified phenotype frequencies and developmental trajectories
phenotypes#Intellectual disability
Show evidence (2 references)
PMID:24907849 SUPPORT Human Clinical
"both affected individuals are males"
The founding report contributes detailed observations from only two affected individuals in one family.
PMID:32737394 SUPPORT Human Clinical
"five members of a consanguineous Pakistani family (Family I) plus two affected children from families of different ethnic origins"
The later report adds seven affected individuals across three families, leaving natural history and unbiased frequencies unresolved.
⚙

Pathophysiology

3
Predicted Impairment of ZNF407 Transcriptional-Regulatory Function
ZNF407 is annotated as a Kruppel-type C2H2 zinc-finger protein. Structural modeling of the biallelic p.S1685W allele predicts impaired target-DNA binding, while experiments in mouse adipocytes demonstrate ZFP407 cofactor activity in a non-neural context. Neither result directly establishes the molecular consequence of a disease allele in human neural cells; the extent of impairment and relevant neural targets remain unknown.
ZNF407 transcriptional-dysregulation model
ZNF407 hgnc:19904 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves ZNF407 (hgnc:19904). hgnc:19904 is a gene from the HUGO Gene Nomenclature Committee.
DNA-binding transcription factor activity GO:0003700 Gene Ontology (GO) Relation: this pathophysiological event involves this molecular function This pathophysiological event involves decreased DNA-binding transcription factor activity (GO:0003700). GO:0003700 is a molecular function from the Gene Ontology. ↓ DECREASED zinc ion binding GO:0008270 Gene Ontology (GO) Relation: this pathophysiological event involves this molecular function This pathophysiological event involves zinc ion binding (GO:0008270). GO:0008270 is a molecular function from the Gene Ontology.
Downstream
Impaired Neurodevelopment ZNF407 transcriptional-dysregulation model
Impaired Somatic Development ZNF407 transcriptional-dysregulation model
Show evidence (3 references)
PMID:23195952 SUPPORT Other
"mutations in genes encoding zinc finger proteins. These proteins modulate gene expression via binding to DNA"
This is generic background about the zinc-finger protein class, not an experimental demonstration of ZNF407 activity or a biallelic disease-allele effect.
PMID:24907849 SUPPORT Computational
"decreased probability of binding to the target DNA sequence essentially eliminating the functionality of downstream domains and interfering with the expression of various genes under ZNF407 control during fetal brain development"
Homology-based structural modeling predicts reduced target-DNA binding; it does not measure binding, downstream expression, or neural effects.
PMID:38781157 SUPPORT In Vitro
"ZFP407 was found to interact with the PPARγ/RXRα protein complex in the nucleus of adipocytes"
The adipocyte experiment demonstrates cofactor activity in a non-neural mouse system but does not test a human disease allele.
Impaired Neurodevelopment
Impaired ZNF407-dependent transcriptional regulation during brain development is hypothesized to impair neurodevelopment, manifesting as intellectual disability, microcephaly, hypotonia and developmental delay.
ZNF407 transcriptional-dysregulation model
nervous system development GO:0007399 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal nervous system development (GO:0007399). GO:0007399 is a biological process from the Gene Ontology. ⚠ ABNORMAL
Downstream
Intellectual disability ZNF407 transcriptional-dysregulation model
Global developmental delay ZNF407 transcriptional-dysregulation model
Motor delay ZNF407 transcriptional-dysregulation model
Delayed speech and language development ZNF407 transcriptional-dysregulation model
Microcephaly ZNF407 transcriptional-dysregulation model
Hypotonia ZNF407 transcriptional-dysregulation model
Gait disturbance Awkward, bent-knee gait acquired only at 4-5 years is part of the motor impairment modeled on the hypothesized neurodevelopmental branch; no intermediate mechanism is established. ZNF407 transcriptional-dysregulation model
Hyperreflexia Exaggerated deep tendon reflexes alongside hypotonia are a central nervous system sign, modeled as an endpoint of the hypothesized neurodevelopmental branch; brain MRI was structurally normal in the founding family, so no anatomic intermediate is established. ZNF407 transcriptional-dysregulation model
Dysarthria Dysarthria is a speech-motor endpoint reported among the cohort's variable features, modeled on the hypothesized neurodevelopmental branch. ZNF407 transcriptional-dysregulation model
Atypical behavior Behavioural anomalies reported in the biallelic cohort are modeled as an endpoint of the hypothesized neurodevelopmental branch. ZNF407 transcriptional-dysregulation model
Enuresis Enuresis, with both founding-family brothers not toilet trained at ages 11 and 5, is modeled as delayed continence acquisition within the hypothesized neurodevelopmental branch. ZNF407 transcriptional-dysregulation model
Encopresis Encopresis reported among the cohort's variable features is modeled as delayed continence acquisition within the hypothesized neurodevelopmental branch. ZNF407 transcriptional-dysregulation model
Show evidence (1 reference)
PMID:32737394 SUPPORT Human Clinical
"All affected individuals from families have intellectual disability (ID), ranging from mild to profound, and reduced motor and cognitive skills"
The cohort documents the clinical neurodevelopmental endpoint but does not establish the proposed upstream transcriptional mechanism.
Impaired Somatic Development
A parallel, untested developmental branch is hypothesized to link altered ZNF407 transcriptional regulation to growth, endocrine, craniofacial, ocular, auditory, and musculoskeletal findings. The literature documents the phenotype cluster but does not identify the relevant cell types, targets, or intermediates.
ZNF407 transcriptional-dysregulation model
Downstream
Short stature ZNF407 transcriptional-dysregulation model
Facial dysmorphism ZNF407 transcriptional-dysregulation model
Ocular anomalies ZNF407 transcriptional-dysregulation model
Hip subluxation ZNF407 transcriptional-dysregulation model
Acetabular dysplasia ZNF407 transcriptional-dysregulation model
Failure to thrive Failure to thrive, with height and weight at or below the 3rd centile in both founding-family brothers, is a growth endpoint of the hypothesized somatic developmental branch. ZNF407 transcriptional-dysregulation model
Delayed puberty Delayed pubertal onset is a growth and endocrine endpoint reported among the cohort's variable features, modeled on the hypothesized somatic developmental branch. ZNF407 transcriptional-dysregulation model
Strabismus Strabismus, documented on physical examination in both founding-family brothers, is an ocular endpoint of the hypothesized somatic developmental branch. ZNF407 transcriptional-dysregulation model
Hearing impairment Deafness of unspecified type is reported among the cohort's variable features; auditory evoked potentials were normal in the founding family, so this is a variable sensory endpoint of the hypothesized somatic developmental branch. ZNF407 transcriptional-dysregulation model
Bilateral ptosis Craniofacial dysmorphic endpoint documented in both founding-family brothers; modeled on the hypothesized somatic developmental branch alongside the generic facial-dysmorphism edge. ZNF407 transcriptional-dysregulation model
Epicanthus Craniofacial dysmorphic endpoint documented in the founding family; modeled on the hypothesized somatic developmental branch. ZNF407 transcriptional-dysregulation model
Synophrys Craniofacial dysmorphic endpoint documented in the founding family but explicitly absent in the later cohort; modeled on the hypothesized somatic developmental branch. ZNF407 transcriptional-dysregulation model
Midface hypoplasia Craniofacial dysmorphic endpoint documented in the founding family but explicitly absent in the later cohort; modeled on the hypothesized somatic developmental branch. ZNF407 transcriptional-dysregulation model
Downturned corners of the mouth Craniofacial dysmorphic endpoint documented in the founding family; modeled on the hypothesized somatic developmental branch. ZNF407 transcriptional-dysregulation model
Thin upper lip vermilion Craniofacial dysmorphic endpoint documented in the founding family; modeled on the hypothesized somatic developmental branch. ZNF407 transcriptional-dysregulation model
Protruding ears Craniofacial dysmorphic endpoint documented in the founding family; modeled on the hypothesized somatic developmental branch. ZNF407 transcriptional-dysregulation model
Camptodactyly of the fifth finger Musculoskeletal endpoint documented in the founding family but explicitly absent in the later cohort; modeled on the hypothesized somatic developmental branch. ZNF407 transcriptional-dysregulation model
Short 4th metatarsal Musculoskeletal endpoint documented in the founding family but explicitly absent in the later cohort; modeled on the hypothesized somatic developmental branch. ZNF407 transcriptional-dysregulation model
Overlapping toes Musculoskeletal endpoint documented in the founding family; modeled on the hypothesized somatic developmental branch. ZNF407 transcriptional-dysregulation model
Prominent fingertip pads Persistent fetal pads on fingers and toes are a limb endpoint documented in the founding family; modeled on the hypothesized somatic developmental branch. ZNF407 transcriptional-dysregulation model
Proximal placement of thumb Bilateral proximal insertion of the thumbs is a limb endpoint documented in the founding family; modeled on the hypothesized somatic developmental branch. ZNF407 transcriptional-dysregulation model
Kyphosis Mild kyphosis on skeletal survey in the founding family, explicitly absent in the later cohort; modeled on the hypothesized somatic developmental branch. ZNF407 transcriptional-dysregulation model
Limited knee mobility Musculoskeletal endpoint documented in the founding family but explicitly absent in the later cohort; modeled on the hypothesized somatic developmental branch. ZNF407 transcriptional-dysregulation model
Show evidence (1 reference)
PMID:32737394 SUPPORT Human Clinical
"All affected individuals from families have intellectual disability (ID), ranging from mild to profound, and reduced motor and cognitive skills plus variable features including short stature, microcephaly, developmental delay, hypotonia, dysarthria, deafness, visual problems, enuresis,..."
The cohort documents a somatic-developmental phenotype cluster but not a causal molecular pathway.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for ZNF407-Related Neurodevelopmental Disorder Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

35
Ear 1
Hearing impairment HP:0000365 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Deafness, annotated with Hearing impairment (HP:0000365). HP:0000365 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:32737394 SUPPORT Human Clinical
"dysarthria, deafness, visual problems, enuresis, encopresis, behavioural anomalies"
Deafness (hearing impairment) is reported among the variable features of the disorder.
Endocrine 1
Delayed puberty HP:0000823 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Delayed pubertal onset, annotated with Delayed puberty (HP:0000823). HP:0000823 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:32737394 SUPPORT Human Clinical
"delayed pubertal onset and facial dysmorphism"
Delayed pubertal onset is reported among the variable features of the disorder.
Eye 1
Strabismus HP:0000486 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Strabismus (HP:0000486). HP:0000486 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:24907849 SUPPORT Human Clinical
"synophrys, strabismus, midface hypoplasia"
Strabismus was documented on physical examination in the founding family.
Head and Neck 4
Microcephaly HP:0000252 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Microcephaly (HP:0000252). HP:0000252 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:32737394 SUPPORT Human Clinical
"variable features including short stature, microcephaly, developmental delay, hypotonia"
Microcephaly is reported among the variable features of the disorder.
Epicanthus HP:0000286 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Epicanthus (HP:0000286). HP:0000286 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:24907849 SUPPORT Human Clinical
"epicanthic folds, synophrys, midface hypoplasia"
Epicanthic folds are a facial dysmorphic feature in the founding family.
Midface hypoplasia Midface retrusion HP:0011800 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Midface hypoplasia, annotated with Midface retrusion (HP:0011800). HP:0011800 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:24907849 SUPPORT Human Clinical
"epicanthic folds, synophrys, midface hypoplasia"
Midface hypoplasia is a facial dysmorphic feature in the founding family.
PMID:32737394 REFUTE Human Clinical
"Affected individuals we present did not exhibit synophrys, midface hypoplasia, kyphosis, 5th finger camptodactyly, short 4th metatarsals or limited knee mobility observed in the reported family"
The later cohort explicitly lacked midface hypoplasia, documenting inter-family phenotypic heterogeneity for this feature.
Facial dysmorphism Abnormal facial shape HP:0001999 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Facial dysmorphism, annotated with Abnormal facial shape (HP:0001999). HP:0001999 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:32737394 SUPPORT Human Clinical
"delayed pubertal onset and facial dysmorphism"
The later cohort exhibited facial dysmorphism as a cohort-level feature, though with different specific features than the founding family.
Integument 1
Prominent fingertip pads HP:0001212 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Persistent fetal fingertip pads, annotated with Prominent fingertip pads (HP:0001212). HP:0001212 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:24907849 SUPPORT Human Clinical
"He had bilateral short fourth metatarsal bones with overriding toes, bilateral proximal insertion of the thumbs and persistent fetal pads on fingers and toes."
Persistent fetal pads on fingers and toes were documented in the founding family.
Limbs 1
Hip subluxation HP:0030043 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Bilateral femoral joint subluxation, annotated with Hip subluxation (HP:0030043). HP:0030043 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:24907849 SUPPORT Human Clinical
"The skeletal survey showed bilateral femoral joint subluxation, dysplastic left acetabulum, and mild kyphosis without scoliosis."
Bilateral hip subluxation was present in the younger founding-family child; the older brother had normal hips.
Musculoskeletal 2
Hypotonia HP:0001252 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hypotonia (HP:0001252). HP:0001252 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:32737394 SUPPORT Human Clinical
"variable features including short stature, microcephaly, developmental delay, hypotonia"
Hypotonia is reported among the variable features of the disorder.
Kyphosis HP:0002808 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Kyphosis (HP:0002808). HP:0002808 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:24907849 SUPPORT Human Clinical
"kyphosis without scoliosis"
Mild kyphosis was documented on skeletal survey in the founding family.
PMID:32737394 REFUTE Human Clinical
"Affected individuals we present did not exhibit synophrys, midface hypoplasia, kyphosis, 5th finger camptodactyly, short 4th metatarsals or limited knee mobility observed in the reported family"
The later cohort explicitly lacked kyphosis, documenting inter-family phenotypic heterogeneity for this feature.
Nervous System 8
Intellectual disability VERY_FREQUENT HP:0001249 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Impaired intellectual development, annotated with Intellectual disability (HP:0001249). HP:0001249 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:32737394 SUPPORT Human Clinical
"All affected individuals from families have intellectual disability (ID), ranging from mild to profound"
Intellectual disability is present in all affected individuals, the obligate feature of the disorder.
Global developmental delay HP:0001263 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Developmental delay, annotated with Global developmental delay (HP:0001263). HP:0001263 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:32737394 SUPPORT Human Clinical
"variable features including short stature, microcephaly, developmental delay, hypotonia"
Developmental delay is reported among the variable features of the disorder.
Motor delay HP:0001270 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Motor delay (HP:0001270). HP:0001270 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:24907849 SUPPORT Human Clinical
"His development has been delayed; he currently sits without support and attempts to pull himself to a stand."
At age five, the younger affected brother could sit independently and was only beginning to pull to stand, directly documenting severe motor delay.
Gait disturbance HP:0001288 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Awkward gait, annotated with Gait disturbance (HP:0001288). HP:0001288 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:24907849 SUPPORT Human Clinical
"walked in- dependently, with an awkward gait and bent knees, be- tween the age of 4 and 5 years"
The older affected brother began walking at four to five years with an awkward, bent-knee gait.
Delayed speech and language development HP:0000750 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Severe speech delay, annotated with Delayed speech and language development (HP:0000750). HP:0000750 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:24907849 SUPPORT Human Clinical
"very limited speech at the age of 8 years"
One founding-family child did not begin very limited speech until age eight; the younger affected brother still only babbled infrequently.
Hyperreflexia HP:0001347 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Exaggerated deep tendon reflexes, annotated with Hyperreflexia (HP:0001347). HP:0001347 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:24907849 SUPPORT Human Clinical
"He is hypotonic with exaggerated deep tendon re- flexes."
Exaggerated deep-tendon reflexes accompanied hypotonia in both affected brothers in the founding family.
Dysarthria HP:0001260 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Dysarthria (HP:0001260). HP:0001260 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:32737394 SUPPORT Human Clinical
"dysarthria, deafness, visual problems, enuresis, encopresis, behavioural anomalies"
Dysarthria is reported among the variable features of the disorder.
Atypical behavior HP:0000708 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Behavioural anomalies, annotated with Atypical behavior (HP:0000708). HP:0000708 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:32737394 SUPPORT Human Clinical
"visual problems, enuresis, encopresis, behavioural anomalies, delayed pubertal onset and facial dysmorphism"
Behavioural anomalies are reported in the biallelic syndromic cohort; autism in earlier heterozygous cases is not generalized to this disorder.
Growth 2
Short stature HP:0004322 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Short stature (HP:0004322). HP:0004322 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:32737394 SUPPORT Human Clinical
"variable features including short stature, microcephaly, developmental delay, hypotonia"
Short stature is reported among the variable features of the disorder.
Failure to thrive HP:0001508 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Failure to thrive (HP:0001508). HP:0001508 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:24907849 SUPPORT Human Clinical
"cognitive impairment, failure-to-thrive, hypotonia and dysmorphic features"
Failure to thrive is a core feature of the founding family's phenotype.
Other 14
Acetabular dysplasia HP:0008807 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Dysplastic left acetabulum, annotated with Acetabular dysplasia (HP:0008807). HP:0008807 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:24907849 SUPPORT Human Clinical
"The skeletal survey showed bilateral femoral joint subluxation, dysplastic left acetabulum, and mild kyphosis without scoliosis."
Left acetabular dysplasia accompanied bilateral hip subluxation in the younger founding-family child.
Ocular anomalies Abnormality of the eye HP:0000478 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Ocular anomalies / visual problems, annotated with Abnormality of the eye (HP:0000478). HP:0000478 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:32737394 SUPPORT Human Clinical
"dysarthria, deafness, visual problems, enuresis, encopresis, behavioural anomalies"
Visual problems (ocular anomalies) are reported among the variable features; ocular anomalies are part of the OMIM/MONDO disease name.
Enuresis HP:0000805 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Enuresis (HP:0000805). HP:0000805 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:32737394 SUPPORT Human Clinical
"dysarthria, deafness, visual problems, enuresis, encopresis, behavioural anomalies"
Enuresis is reported among the variable features of the disorder.
Encopresis HP:0040183 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Encopresis (HP:0040183). HP:0040183 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:32737394 SUPPORT Human Clinical
"dysarthria, deafness, visual problems, enuresis, encopresis, behavioural anomalies"
Encopresis is reported among the variable features of the disorder.
Bilateral ptosis HP:0001488 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Bilateral ptosis (HP:0001488). HP:0001488 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:24907849 SUPPORT Human Clinical
"dysmorphic features including bilateral ptosis"
Bilateral ptosis is a facial dysmorphic feature in the founding family.
Synophrys HP:0000664 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Synophrys (HP:0000664). HP:0000664 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:24907849 SUPPORT Human Clinical
"epicanthic folds, synophrys, midface hypoplasia"
Synophrys is a facial dysmorphic feature in the founding family.
PMID:32737394 REFUTE Human Clinical
"Affected individuals we present did not exhibit synophrys, midface hypoplasia, kyphosis, 5th finger camptodactyly, short 4th metatarsals or limited knee mobility observed in the reported family"
The later cohort explicitly lacked synophrys, documenting inter-family phenotypic heterogeneity for this feature.
Downturned corners of the mouth Downturned corners of mouth HP:0002714 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Downturned corners of the mouth, annotated with Downturned corners of mouth (HP:0002714). HP:0002714 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:24907849 SUPPORT Human Clinical
"midface hypoplasia, downturned mouth corners, thin upper vermillion border"
Downturned corners of the mouth are a facial dysmorphic feature in the founding family.
Thin upper lip vermilion HP:0000219 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Thin upper lip vermilion (HP:0000219). HP:0000219 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:24907849 SUPPORT Human Clinical
"downturned mouth corners, thin upper vermillion border and"
A thin upper vermilion border is a facial dysmorphic feature in the founding family.
Protruding ears HP:0000411 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Prominent ears, annotated with Protruding ear (HP:0000411). HP:0000411 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:24907849 SUPPORT Human Clinical
"prominent ears, bilateral 5th finger camptodactyly"
Prominent ears are a facial dysmorphic feature in the founding family.
Camptodactyly of the fifth finger Joint contracture of the 5th finger HP:0009183 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Camptodactyly of the fifth finger, annotated with Joint contracture of the 5th finger (HP:0009183). HP:0009183 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:24907849 SUPPORT Human Clinical
"prominent ears, bilateral 5th finger camptodactyly"
Bilateral 5th-finger camptodactyly is a limb feature in the founding family.
PMID:32737394 REFUTE Human Clinical
"Affected individuals we present did not exhibit synophrys, midface hypoplasia, kyphosis, 5th finger camptodactyly, short 4th metatarsals or limited knee mobility observed in the reported family"
The later cohort explicitly lacked 5th-finger camptodactyly, documenting inter-family phenotypic heterogeneity for this feature.
Short 4th metatarsal Short fourth metatarsal HP:0004689 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Short 4th metatarsal, annotated with Short fourth metatarsal (HP:0004689). HP:0004689 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:24907849 SUPPORT Human Clinical
"bilateral short 4th metatarsal bones, and limited knee mobility"
Bilateral short 4th metatarsal bones are a limb feature in the founding family.
PMID:32737394 REFUTE Human Clinical
"Affected individuals we present did not exhibit synophrys, midface hypoplasia, kyphosis, 5th finger camptodactyly, short 4th metatarsals or limited knee mobility observed in the reported family"
The later cohort explicitly lacked short 4th metatarsals, documenting inter-family phenotypic heterogeneity for this feature.
Overlapping toes HP:0001845 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Overriding toes, annotated with Overlapping toe (HP:0001845). HP:0001845 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:24907849 SUPPORT Human Clinical
"He had bilateral short fourth metatarsal bones with overriding toes, bilateral proximal insertion of the thumbs and persistent fetal pads on fingers and toes."
Overriding toes were documented in the founding family.
Proximal placement of thumb HP:0009623 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Bilateral proximal insertion of the thumbs, annotated with Proximal placement of thumb (HP:0009623). HP:0009623 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:24907849 SUPPORT Human Clinical
"He had bilateral short fourth metatarsal bones with overriding toes, bilateral proximal insertion of the thumbs and persistent fetal pads on fingers and toes."
Bilateral proximal insertion of the thumbs was documented on physical examination in both affected brothers of the founding family.
Limited knee mobility Limited knee flexion/extension HP:0005085 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Limited knee mobility, annotated with Limited knee flexion/extension (HP:0005085). HP:0005085 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:24907849 SUPPORT Human Clinical
"bilateral short 4th metatarsal bones, and limited knee mobility"
Limited knee mobility was documented bilaterally in the founding family.
PMID:32737394 REFUTE Human Clinical
"Affected individuals we present did not exhibit synophrys, midface hypoplasia, kyphosis, 5th finger camptodactyly, short 4th metatarsals or limited knee mobility observed in the reported family"
The later cohort explicitly lacked limited knee mobility, documenting inter-family phenotypic heterogeneity for this feature.
🧬

Genetic Associations

1
ZNF407
Gene: ZNF407 hgnc:19904 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is ZNF407 (hgnc:19904). hgnc:19904 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE
Show evidence (2 references)
PMID:32737394 SUPPORT Human Clinical
"we detected homozygous c.2405G>T (p.Gly802Val) in the affected member of Family II and compound heterozygous variants c.2884C>G (p.Arg962Gly) and c.3642G>C (p.Lys1214Asn) in the affected member of Family III"
Documents additional homozygous and compound heterozygous ZNF407 variants in independent families, establishing biallelic ZNF407 variation as the molecular cause.
PMID:24907849 SUPPORT Human Clinical
"A damaging c.C5054G mutation affecting an evolutionary highly conserved amino acid p.S1685W was identified in the ZNF407 gene at 18q23"
Identifies the founding homozygous ZNF407 variant (p.S1685W) at 18q23 in the first-reported family, establishing ZNF407 as the causal gene.
🔬

Diagnosis

1
Reported Molecular Testing for Biallelic ZNF407 Variants
Published families were identified through homozygosity mapping and/or exome sequencing, followed by segregation assessment of biallelic ZNF407 variants in affected relatives where samples were available. These are the reported study workflows, not a formally established testing requirement; the literature does not establish a validated clinical scoring system or disease-specific functional assay.
Show evidence (2 references)
PMID:32737394 SUPPORT Human Clinical
"by exome sequencing identified homozygous ZNF407 c.2814_2816dup (p.Val939dup) in four affected members"
Exome sequencing identified the homozygous variant in the largest published family.
PMID:24907849 SUPPORT Human Clinical
"The family was studied by homozygosity mapping, candidate gene mutation screening and whole Exome Next Generation Sequencing"
The founding family was solved through homozygosity mapping followed by sequence analysis.
📊

Prevalence

1
Worldwide
Cases In Literature Not yet documented
No population prevalence or incidence estimate has been published. The core biallelic syndrome is represented by nine published affected individuals from four families: two brothers in the founding consanguineous Arab family (PMID:24907849) and seven individuals from three families in the 2020 expansion (PMID:32737394). The heterozygous translocation and missense cases reported in PMID:23195952 are not counted because they do not establish the same recessive entity. Ascertainment is genotype-first, so this case count is not a population rate.
Show evidence (2 references)
PMID:32737394 SUPPORT Human Clinical
"Homozygous c.5054C>G (p.Ser1685Trp) has been reported in two brothers with an ID syndrome"
The later cohort report directly summarizes the two affected brothers with the homozygous p.S1685W variant in the founding family.
PMID:32737394 SUPPORT Human Clinical
"five members of a consanguineous Pakistani family (Family I) plus two affected children from families of different ethnic origins"
The expansion describes seven affected individuals from three additional families, supporting the literature case count without implying a population prevalence.
{ }

Source YAML

click to show 
name: ZNF407-Related Neurodevelopmental Disorder
creation_date: "2026-08-01T00:00:00Z"
category: Mendelian
synonyms:
- short stature, impaired intellectual development, microcephaly, hypotonia, and ocular anomalies
- SIMHOA
- ZNF407-related intellectual disability
description: >
  ZNF407-related neurodevelopmental disorder is a rare autosomal recessive
  condition caused by biallelic damaging variants in ZNF407 (18q23), which
  encodes a large Kruppel-type C2H2 zinc-finger protein. Transcriptional
  impairment is predicted from structural modeling of one disease allele, and
  cofactor activity has been demonstrated only in mouse adipocytes. Complete
  loss of function has not been demonstrated for the reported biallelic
  missense and in-frame variants. OMIM/MONDO
  name the entity after its core clinical features: short stature, impaired
  intellectual development (intellectual disability), microcephaly, hypotonia,
  and ocular anomalies. Intellectual disability (mild to profound) is the
  obligate feature; short stature, microcephaly, developmental delay, hypotonia,
  dysarthria, hearing loss, visual problems, behavioural anomalies, delayed
  puberty and facial dysmorphism are variable.
  ZNF407 was first implicated in non-syndromic intellectual disability with
  autism through a balanced translocation disrupting the gene and heterozygous
  linker-region missense variants predicted to impair zinc-finger function;
  those observations do not establish the same recessive syndrome. The
  recessive syndromic entity was delineated in a consanguineous Arab family
  homozygous for the p.S1685W linker variant (2014), then expanded allelically
  and phenotypically in additional families with biallelic variants (2020).
disease_term:
  preferred_term: short stature, impaired intellectual development, microcephaly, hypotonia, and ocular anomalies
  term:
    id: MONDO:0859198
    label: short stature, impaired intellectual development, microcephaly, hypotonia, and ocular anomalies
parents:
- Neurodevelopmental disorder
- Autosomal recessive disease
prevalence:
- population: Worldwide
  measure_type: CASES_IN_LITERATURE
  prevalence_class: NOT_YET_DOCUMENTED
  notes: >-
    No population prevalence or incidence estimate has been published. The
    core biallelic syndrome is represented by nine published affected
    individuals from four families: two brothers in the founding consanguineous
    Arab family (PMID:24907849) and seven individuals from three families in the
    2020 expansion (PMID:32737394). The heterozygous translocation and missense
    cases reported in PMID:23195952 are not counted because they do not establish
    the same recessive entity. Ascertainment is genotype-first, so this case
    count is not a population rate.
  evidence:
  - reference: PMID:32737394
    reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Homozygous c.5054C>G (p.Ser1685Trp) has been reported in two brothers with an ID syndrome"
    explanation: >-
      The later cohort report directly summarizes the two affected brothers
      with the homozygous p.S1685W variant in the founding family.
  - reference: PMID:32737394
    reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "five members of a consanguineous Pakistani family (Family I) plus two affected children from families of different ethnic origins"
    explanation: >-
      The expansion describes seven affected individuals from three additional
      families, supporting the literature case count without implying a
      population prevalence.
inheritance:
- name: Autosomal recessive
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  description: >
    Biallelic (homozygous or compound heterozygous) ZNF407 variants segregate
    with the phenotype in reported consanguineous and non-consanguineous
    families.
  evidence:
  - reference: PMID:32737394
    reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "by exome sequencing identified homozygous ZNF407 c.2814_2816dup (p.Val939dup) in four affected members"
    explanation: >
      Homozygous ZNF407 variant identified in multiple affected members of a
      consanguineous family, consistent with autosomal recessive inheritance.
  - reference: PMID:24907849
    reference_title: "Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A consanguineous Arab family is affected by an apparently novel autosomal recessive disorder characterized by cognitive impairment, failure-to-thrive, hypotonia and dysmorphic features"
    explanation: >
      Foundational report delineating the autosomal recessive ZNF407 disorder in
      an independent consanguineous family.
genetic:
- name: ZNF407
  gene_term:
    preferred_term: ZNF407
    term:
      id: hgnc:19904
      label: ZNF407
  relationship_type: CAUSATIVE
  notes: >
    ZNF407 (18q23) encodes a large Kruppel-type C2H2 zinc-finger transcription
    factor. Reported biallelic variants include homozygous c.2814_2816dup
    (p.Val939dup), homozygous c.2405G>T (p.Gly802Val), compound heterozygous
    c.2884C>G (p.Arg962Gly) / c.3642G>C (p.Lys1214Asn), and homozygous
    c.5054C>G (p.Ser1685Trp). This causative relationship is limited to the
    biallelic recessive disorder; earlier heterozygous observations are not
    included as evidence for it.
  evidence:
  - reference: PMID:32737394
    reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "we detected homozygous c.2405G>T (p.Gly802Val) in the affected member of Family II and compound heterozygous variants c.2884C>G (p.Arg962Gly) and c.3642G>C (p.Lys1214Asn) in the affected member of Family III"
    explanation: >
      Documents additional homozygous and compound heterozygous ZNF407 variants
      in independent families, establishing biallelic ZNF407 variation as the
      molecular cause.
  - reference: PMID:24907849
    reference_title: "Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A damaging c.C5054G mutation affecting an evolutionary highly conserved amino acid p.S1685W was identified in the ZNF407 gene at 18q23"
    explanation: >
      Identifies the founding homozygous ZNF407 variant (p.S1685W) at 18q23 in
      the first-reported family, establishing ZNF407 as the causal gene.
mechanistic_hypotheses:
- hypothesis_group_id: znf407_transcriptional_dysregulation
  hypothesis_label: ZNF407 transcriptional-dysregulation model
  status: EMERGING
  description: >-
    The current disease model proposes that biallelic damaging variants impair
    ZNF407 zinc-finger or cofactor function, altering transcription during fetal
    brain development and thereby causing the neurodevelopmental phenotype.
    Disease-specific support is limited to segregation and computational
    structural modeling of p.S1685W; no patient-derived neural assay has shown
    altered DNA occupancy, target-gene expression, or rescue. A 2024 study
    directly demonstrated ZFP407 cofactor activity in mouse adipocytes, but did
    not test human neurodevelopment or any disease allele.
  evidence:
  - reference: PMID:24907849
    reference_title: "Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome."
    supports: SUPPORT
    evidence_source: COMPUTATIONAL
    snippet: "Structural analyses of this mutation shows disruption of an H-bond"
    explanation: >-
      Structural modeling supports impaired zinc-finger geometry but does not
      directly demonstrate altered transcription in patient neural cells.
  - reference: PMID:38781157
    reference_title: "Molecular regulation of PPARγ/RXRα signaling by the novel cofactor ZFP407."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "ZFP407 was found to interact with the PPARγ/RXRα protein complex in the nucleus of adipocytes"
    explanation: >-
      Establishes transcriptional-cofactor activity in an adipocyte system, but
      only indirectly informs the neurodevelopmental disease mechanism.
pathophysiology:
- name: Predicted Impairment of ZNF407 Transcriptional-Regulatory Function
  biological_scale: MOLECULAR
  mechanism_confidence: PROVISIONAL
  description: >
    ZNF407 is annotated as a Kruppel-type C2H2 zinc-finger protein. Structural
    modeling of the biallelic p.S1685W allele predicts impaired target-DNA
    binding, while experiments in mouse adipocytes demonstrate ZFP407 cofactor
    activity in a non-neural context. Neither result directly establishes the
    molecular consequence of a disease allele in human neural cells; the
    extent of impairment and relevant neural targets remain unknown.
  genes:
  - preferred_term: ZNF407
    term:
      id: hgnc:19904
      label: ZNF407
  molecular_functions:
  - preferred_term: DNA-binding transcription factor activity
    term:
      id: GO:0003700
      label: DNA-binding transcription factor activity
    modifier: DECREASED
  - preferred_term: zinc ion binding
    term:
      id: GO:0008270
      label: zinc ion binding
  downstream:
  - target: Impaired Neurodevelopment
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    evidence:
    - reference: PMID:24907849
      reference_title: "Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome."
      supports: SUPPORT
      evidence_source: COMPUTATIONAL
      snippet: "interfering with the expression of various genes under ZNF407 control during fetal brain development"
      explanation: >-
        The computational model proposes the molecular-to-developmental link;
        it has not been tested in patient-derived neural cells.
  - target: Impaired Somatic Development
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    evidence:
    - reference: PMID:32737394
      reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "All affected individuals from families have intellectual disability (ID), ranging from mild to profound, and reduced motor and cognitive skills plus variable features including short stature, microcephaly, developmental delay, hypotonia, dysarthria, deafness, visual problems, enuresis, encopresis, behavioural anomalies, delayed pubertal onset and facial dysmorphism"
      explanation: >-
        The cohort establishes a multisystem developmental phenotype but does
        not test the proposed transcriptional route to those findings.
  evidence:
  - reference: PMID:23195952
    reference_title: "Balanced translocation t(3;18)(p13;q22.3) and points mutation in the ZNF407 gene detected in patients with both moderate non-syndromic intellectual disability and autism."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "mutations in genes encoding zinc finger proteins. These proteins modulate gene expression via binding to DNA"
    explanation: >-
      This is generic background about the zinc-finger protein class, not an
      experimental demonstration of ZNF407 activity or a biallelic
      disease-allele effect.
  - reference: PMID:24907849
    reference_title: "Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome."
    supports: SUPPORT
    evidence_source: COMPUTATIONAL
    snippet: "decreased probability of binding to the target DNA sequence essentially eliminating the functionality of downstream domains and interfering with the expression of various genes under ZNF407 control during fetal brain development"
    explanation: >-
      Homology-based structural modeling predicts reduced target-DNA binding;
      it does not measure binding, downstream expression, or neural effects.
  - reference: PMID:38781157
    reference_title: "Molecular regulation of PPARγ/RXRα signaling by the novel cofactor ZFP407."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "ZFP407 was found to interact with the PPARγ/RXRα protein complex in the nucleus of adipocytes"
    explanation: >-
      The adipocyte experiment demonstrates cofactor activity in a non-neural
      mouse system but does not test a human disease allele.
- name: Impaired Neurodevelopment
  biological_scale: TISSUE
  mechanism_confidence: HYPOTHETICAL
  description: >
    Impaired ZNF407-dependent transcriptional regulation during brain
    development is hypothesized to impair neurodevelopment, manifesting as
    intellectual disability, microcephaly, hypotonia and developmental delay.
  biological_processes:
  - preferred_term: nervous system development
    term:
      id: GO:0007399
      label: nervous system development
    modifier: ABNORMAL
  downstream:
  - target: Intellectual disability
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    evidence:
    - reference: PMID:32737394
      reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "All affected individuals from families have intellectual disability (ID), ranging from mild to profound"
      explanation: >-
        Intellectual disability is the universal clinical endpoint of the
        hypothesized neurodevelopmental branch.
  - target: Global developmental delay
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    evidence:
    - reference: PMID:32737394
      reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "variable features including short stature, microcephaly, developmental delay, hypotonia"
      explanation: >-
        Developmental delay is a reported clinical endpoint of the
        neurodevelopmental branch.
  - target: Motor delay
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    evidence:
    - reference: PMID:32737394
      reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "reduced motor and cognitive skills plus variable features including short stature, microcephaly, developmental delay, hypotonia"
      explanation: >-
        Reduced motor skills directly support motor delay as an endpoint of the
        neurodevelopmental branch.
  - target: Delayed speech and language development
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    evidence:
    - reference: PMID:24907849
      reference_title: "Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "very limited speech at the age of 8 years"
      explanation: >-
        Severe speech delay is a reported endpoint in the founding family.
  - target: Microcephaly
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    evidence:
    - reference: PMID:32737394
      reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "variable features including short stature, microcephaly, developmental delay, hypotonia"
      explanation: >-
        Microcephaly is a reported endpoint of the hypothesized
        neurodevelopmental branch.
  - target: Hypotonia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    evidence:
    - reference: PMID:32737394
      reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "variable features including short stature, microcephaly, developmental delay, hypotonia"
      explanation: >-
        Hypotonia is a reported endpoint of the hypothesized
        neurodevelopmental branch.
  - target: Gait disturbance
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    description: >-
      Awkward, bent-knee gait acquired only at 4-5 years is part of the motor
      impairment modeled on the hypothesized neurodevelopmental branch; no
      intermediate mechanism is established.
  - target: Hyperreflexia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    description: >-
      Exaggerated deep tendon reflexes alongside hypotonia are a central
      nervous system sign, modeled as an endpoint of the hypothesized
      neurodevelopmental branch; brain MRI was structurally normal in the
      founding family, so no anatomic intermediate is established.
  - target: Dysarthria
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    description: >-
      Dysarthria is a speech-motor endpoint reported among the cohort's
      variable features, modeled on the hypothesized neurodevelopmental
      branch.
  - target: Atypical behavior
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    description: >-
      Behavioural anomalies reported in the biallelic cohort are modeled as an
      endpoint of the hypothesized neurodevelopmental branch.
  - target: Enuresis
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    description: >-
      Enuresis, with both founding-family brothers not toilet trained at ages
      11 and 5, is modeled as delayed continence acquisition within the
      hypothesized neurodevelopmental branch.
  - target: Encopresis
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    description: >-
      Encopresis reported among the cohort's variable features is modeled as
      delayed continence acquisition within the hypothesized
      neurodevelopmental branch.
  evidence:
  - reference: PMID:32737394
    reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All affected individuals from families have intellectual disability (ID), ranging from mild to profound, and reduced motor and cognitive skills"
    explanation: >
      The cohort documents the clinical neurodevelopmental endpoint but does
      not establish the proposed upstream transcriptional mechanism.
- name: Impaired Somatic Development
  biological_scale: TISSUE
  mechanism_confidence: HYPOTHETICAL
  description: >-
    A parallel, untested developmental branch is hypothesized to link altered
    ZNF407 transcriptional regulation to growth, endocrine, craniofacial,
    ocular, auditory, and musculoskeletal findings. The literature documents
    the phenotype cluster but does not identify the relevant cell types,
    targets, or intermediates.
  downstream:
  - target: Short stature
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    evidence:
    - reference: PMID:32737394
      reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "variable features including short stature, microcephaly, developmental delay, hypotonia"
      explanation: >-
        Short stature is a reported endpoint of the hypothesized somatic
        developmental branch.
  - target: Facial dysmorphism
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    evidence:
    - reference: PMID:32737394
      reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "delayed pubertal onset and facial dysmorphism"
      explanation: >-
        Facial dysmorphism is a reported endpoint of the hypothesized somatic
        developmental branch.
  - target: Ocular anomalies
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    evidence:
    - reference: PMID:32737394
      reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "dysarthria, deafness, visual problems, enuresis, encopresis, behavioural anomalies"
      explanation: >-
        Ocular or visual abnormalities are a reported endpoint of the
        hypothesized somatic developmental branch.
  - target: Hip subluxation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    evidence:
    - reference: PMID:24907849
      reference_title: "Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "The skeletal survey\nshowed bilateral femoral joint subluxation, dysplastic left\nacetabulum, and mild kyphosis without scoliosis."
      explanation: >-
        Hip subluxation is a reported musculoskeletal endpoint in the founding
        family.
  - target: Acetabular dysplasia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    evidence:
    - reference: PMID:24907849
      reference_title: "Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "The skeletal survey\nshowed bilateral femoral joint subluxation, dysplastic left\nacetabulum, and mild kyphosis without scoliosis."
      explanation: >-
        Acetabular dysplasia is a reported musculoskeletal endpoint in the
        founding family.
  - target: Failure to thrive
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    description: >-
      Failure to thrive, with height and weight at or below the 3rd centile in
      both founding-family brothers, is a growth endpoint of the hypothesized
      somatic developmental branch.
  - target: Delayed puberty
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    description: >-
      Delayed pubertal onset is a growth and endocrine endpoint reported among
      the cohort's variable features, modeled on the hypothesized somatic
      developmental branch.
  - target: Strabismus
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    description: >-
      Strabismus, documented on physical examination in both founding-family
      brothers, is an ocular endpoint of the hypothesized somatic
      developmental branch.
  - target: Hearing impairment
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    description: >-
      Deafness of unspecified type is reported among the cohort's variable
      features; auditory evoked potentials were normal in the founding family,
      so this is a variable sensory endpoint of the hypothesized somatic
      developmental branch.
  - target: Bilateral ptosis
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    description: >-
      Craniofacial dysmorphic endpoint documented in both founding-family
      brothers; modeled on the hypothesized somatic developmental branch
      alongside the generic facial-dysmorphism edge.
  - target: Epicanthus
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    description: >-
      Craniofacial dysmorphic endpoint documented in the founding family;
      modeled on the hypothesized somatic developmental branch.
  - target: Synophrys
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    description: >-
      Craniofacial dysmorphic endpoint documented in the founding family but
      explicitly absent in the later cohort; modeled on the hypothesized
      somatic developmental branch.
  - target: Midface hypoplasia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    description: >-
      Craniofacial dysmorphic endpoint documented in the founding family but
      explicitly absent in the later cohort; modeled on the hypothesized
      somatic developmental branch.
  - target: Downturned corners of the mouth
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    description: >-
      Craniofacial dysmorphic endpoint documented in the founding family;
      modeled on the hypothesized somatic developmental branch.
  - target: Thin upper lip vermilion
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    description: >-
      Craniofacial dysmorphic endpoint documented in the founding family;
      modeled on the hypothesized somatic developmental branch.
  - target: Protruding ears
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    description: >-
      Craniofacial dysmorphic endpoint documented in the founding family;
      modeled on the hypothesized somatic developmental branch.
  - target: Camptodactyly of the fifth finger
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    description: >-
      Musculoskeletal endpoint documented in the founding family but
      explicitly absent in the later cohort; modeled on the hypothesized
      somatic developmental branch.
  - target: Short 4th metatarsal
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    description: >-
      Musculoskeletal endpoint documented in the founding family but
      explicitly absent in the later cohort; modeled on the hypothesized
      somatic developmental branch.
  - target: Overlapping toes
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    description: >-
      Musculoskeletal endpoint documented in the founding family; modeled on
      the hypothesized somatic developmental branch.
  - target: Prominent fingertip pads
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    description: >-
      Persistent fetal pads on fingers and toes are a limb endpoint documented
      in the founding family; modeled on the hypothesized somatic
      developmental branch.
  - target: Proximal placement of thumb
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    description: >-
      Bilateral proximal insertion of the thumbs is a limb endpoint documented
      in the founding family; modeled on the hypothesized somatic
      developmental branch.
  - target: Kyphosis
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    description: >-
      Mild kyphosis on skeletal survey in the founding family, explicitly
      absent in the later cohort; modeled on the hypothesized somatic
      developmental branch.
  - target: Limited knee mobility
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - znf407_transcriptional_dysregulation
    description: >-
      Musculoskeletal endpoint documented in the founding family but
      explicitly absent in the later cohort; modeled on the hypothesized
      somatic developmental branch.
  evidence:
  - reference: PMID:32737394
    reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All affected individuals from families have intellectual disability (ID), ranging from mild to profound, and reduced motor and cognitive skills plus variable features including short stature, microcephaly, developmental delay, hypotonia, dysarthria, deafness, visual problems, enuresis, encopresis, behavioural anomalies, delayed pubertal onset and facial dysmorphism"
    explanation: >-
      The cohort documents a somatic-developmental phenotype cluster but not a
      causal molecular pathway.
phenotypes:
- name: Intellectual disability
  phenotype_term:
    preferred_term: Impaired intellectual development
    term:
      id: HP:0001249
      label: Intellectual disability
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:32737394
    reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All affected individuals from families have intellectual disability (ID), ranging from mild to profound"
    explanation: >
      Intellectual disability is present in all affected individuals, the
      obligate feature of the disorder.
- name: Short stature
  phenotype_term:
    preferred_term: Short stature
    term:
      id: HP:0004322
      label: Short stature
  evidence:
  - reference: PMID:32737394
    reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "variable features including short stature, microcephaly, developmental delay, hypotonia"
    explanation: >
      Short stature is reported among the variable features of the disorder.
- name: Microcephaly
  phenotype_term:
    preferred_term: Microcephaly
    term:
      id: HP:0000252
      label: Microcephaly
  evidence:
  - reference: PMID:32737394
    reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "variable features including short stature, microcephaly, developmental delay, hypotonia"
    explanation: >
      Microcephaly is reported among the variable features of the disorder.
- name: Hypotonia
  phenotype_term:
    preferred_term: Hypotonia
    term:
      id: HP:0001252
      label: Hypotonia
  evidence:
  - reference: PMID:32737394
    reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "variable features including short stature, microcephaly, developmental delay, hypotonia"
    explanation: >
      Hypotonia is reported among the variable features of the disorder.
- name: Global developmental delay
  phenotype_term:
    preferred_term: Developmental delay
    term:
      id: HP:0001263
      label: Global developmental delay
  evidence:
  - reference: PMID:32737394
    reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "variable features including short stature, microcephaly, developmental delay, hypotonia"
    explanation: >
      Developmental delay is reported among the variable features of the
      disorder.
- name: Motor delay
  phenotype_term:
    preferred_term: Motor delay
    term:
      id: HP:0001270
      label: Motor delay
  evidence:
  - reference: PMID:24907849
    reference_title: "Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "His development\nhas been delayed; he currently sits without support and\nattempts to pull himself to a stand."
    explanation: >-
      At age five, the younger affected brother could sit independently and was
      only beginning to pull to stand, directly documenting severe motor delay.
- name: Gait disturbance
  phenotype_term:
    preferred_term: Awkward gait
    term:
      id: HP:0001288
      label: Gait disturbance
  evidence:
  - reference: PMID:24907849
    reference_title: "Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "walked in-\ndependently, with an awkward gait and bent knees, be-\ntween the age of 4 and 5 years"
    explanation: >-
      The older affected brother began walking at four to five years with an
      awkward, bent-knee gait.
- name: Delayed speech and language development
  phenotype_term:
    preferred_term: Severe speech delay
    term:
      id: HP:0000750
      label: Delayed speech and language development
  evidence:
  - reference: PMID:24907849
    reference_title: "Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "very limited speech at the age of 8 years"
    explanation: >-
      One founding-family child did not begin very limited speech until age
      eight; the younger affected brother still only babbled infrequently.
- name: Hyperreflexia
  phenotype_term:
    preferred_term: Exaggerated deep tendon reflexes
    term:
      id: HP:0001347
      label: Hyperreflexia
  evidence:
  - reference: PMID:24907849
    reference_title: "Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: |-
      He is hypotonic with exaggerated deep tendon re-
      flexes.
    explanation: >-
      Exaggerated deep-tendon reflexes accompanied hypotonia in both affected
      brothers in the founding family.
- name: Hip subluxation
  phenotype_term:
    preferred_term: Bilateral femoral joint subluxation
    term:
      id: HP:0030043
      label: Hip subluxation
  evidence:
  - reference: PMID:24907849
    reference_title: "Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The skeletal survey\nshowed bilateral femoral joint subluxation, dysplastic left\nacetabulum, and mild kyphosis without scoliosis."
    explanation: >-
      Bilateral hip subluxation was present in the younger founding-family
      child; the older brother had normal hips.
- name: Acetabular dysplasia
  phenotype_term:
    preferred_term: Dysplastic left acetabulum
    term:
      id: HP:0008807
      label: Acetabular dysplasia
  evidence:
  - reference: PMID:24907849
    reference_title: "Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The skeletal survey\nshowed bilateral femoral joint subluxation, dysplastic left\nacetabulum, and mild kyphosis without scoliosis."
    explanation: >-
      Left acetabular dysplasia accompanied bilateral hip subluxation in the
      younger founding-family child.
- name: Ocular anomalies
  phenotype_term:
    preferred_term: Ocular anomalies / visual problems
    term:
      id: HP:0000478
      label: Abnormality of the eye
  evidence:
  - reference: PMID:32737394
    reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "dysarthria, deafness, visual problems, enuresis, encopresis, behavioural anomalies"
    explanation: >
      Visual problems (ocular anomalies) are reported among the variable
      features; ocular anomalies are part of the OMIM/MONDO disease name.
- name: Hearing impairment
  phenotype_term:
    preferred_term: Deafness
    term:
      id: HP:0000365
      label: Hearing impairment
  evidence:
  - reference: PMID:32737394
    reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "dysarthria, deafness, visual problems, enuresis, encopresis, behavioural anomalies"
    explanation: >
      Deafness (hearing impairment) is reported among the variable features of
      the disorder.
- name: Dysarthria
  phenotype_term:
    preferred_term: Dysarthria
    term:
      id: HP:0001260
      label: Dysarthria
  evidence:
  - reference: PMID:32737394
    reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "dysarthria, deafness, visual problems, enuresis, encopresis, behavioural anomalies"
    explanation: >
      Dysarthria is reported among the variable features of the disorder.
- name: Atypical behavior
  phenotype_term:
    preferred_term: Behavioural anomalies
    term:
      id: HP:0000708
      label: Atypical behavior
  evidence:
  - reference: PMID:32737394
    reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "visual problems, enuresis, encopresis, behavioural anomalies, delayed pubertal onset and facial dysmorphism"
    explanation: >-
      Behavioural anomalies are reported in the biallelic syndromic cohort;
      autism in earlier heterozygous cases is not generalized to this disorder.
- name: Failure to thrive
  phenotype_term:
    preferred_term: Failure to thrive
    term:
      id: HP:0001508
      label: Failure to thrive
  evidence:
  - reference: PMID:24907849
    reference_title: "Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "cognitive impairment, failure-to-thrive, hypotonia and dysmorphic features"
    explanation: >
      Failure to thrive is a core feature of the founding family's phenotype.
- name: Enuresis
  phenotype_term:
    preferred_term: Enuresis
    term:
      id: HP:0000805
      label: Enuresis
  evidence:
  - reference: PMID:32737394
    reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "dysarthria, deafness, visual problems, enuresis, encopresis, behavioural anomalies"
    explanation: >
      Enuresis is reported among the variable features of the disorder.
- name: Encopresis
  phenotype_term:
    preferred_term: Encopresis
    term:
      id: HP:0040183
      label: Encopresis
  evidence:
  - reference: PMID:32737394
    reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "dysarthria, deafness, visual problems, enuresis, encopresis, behavioural anomalies"
    explanation: >
      Encopresis is reported among the variable features of the disorder.
- name: Bilateral ptosis
  phenotype_term:
    preferred_term: Bilateral ptosis
    term:
      id: HP:0001488
      label: Bilateral ptosis
  evidence:
  - reference: PMID:24907849
    reference_title: "Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "dysmorphic features including bilateral ptosis"
    explanation: >
      Bilateral ptosis is a facial dysmorphic feature in the founding family.
- name: Epicanthus
  phenotype_term:
    preferred_term: Epicanthus
    term:
      id: HP:0000286
      label: Epicanthus
  evidence:
  - reference: PMID:24907849
    reference_title: "Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "epicanthic folds, synophrys, midface hypoplasia"
    explanation: >
      Epicanthic folds are a facial dysmorphic feature in the founding family.
- name: Synophrys
  phenotype_term:
    preferred_term: Synophrys
    term:
      id: HP:0000664
      label: Synophrys
  evidence:
  - reference: PMID:24907849
    reference_title: "Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "epicanthic folds, synophrys, midface hypoplasia"
    explanation: >
      Synophrys is a facial dysmorphic feature in the founding family.
  - reference: PMID:32737394
    reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: "Affected individuals we present did not exhibit synophrys, midface \nhypoplasia, kyphosis, 5th finger camptodactyly, short 4th metatarsals or limited \nknee mobility observed in the reported family"
    explanation: >
      The later cohort explicitly lacked synophrys, documenting inter-family
      phenotypic heterogeneity for this feature.
- name: Strabismus
  phenotype_term:
    preferred_term: Strabismus
    term:
      id: HP:0000486
      label: Strabismus
  evidence:
  - reference: PMID:24907849
    reference_title: "Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "synophrys, strabismus, midface hypoplasia"
    explanation: >
      Strabismus was documented on physical examination in the founding family.
- name: Midface hypoplasia
  phenotype_term:
    preferred_term: Midface hypoplasia
    term:
      id: HP:0011800
      label: Midface retrusion
  evidence:
  - reference: PMID:24907849
    reference_title: "Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "epicanthic folds, synophrys, midface hypoplasia"
    explanation: >
      Midface hypoplasia is a facial dysmorphic feature in the founding family.
  - reference: PMID:32737394
    reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: "Affected individuals we present did not exhibit synophrys, midface \nhypoplasia, kyphosis, 5th finger camptodactyly, short 4th metatarsals or limited \nknee mobility observed in the reported family"
    explanation: >
      The later cohort explicitly lacked midface hypoplasia, documenting
      inter-family phenotypic heterogeneity for this feature.
- name: Downturned corners of the mouth
  phenotype_term:
    preferred_term: Downturned corners of the mouth
    term:
      id: HP:0002714
      label: Downturned corners of mouth
  evidence:
  - reference: PMID:24907849
    reference_title: "Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "midface hypoplasia, downturned mouth corners, thin upper vermillion border"  # codespell:ignore-line
    explanation: >
      Downturned corners of the mouth are a facial dysmorphic feature in the
      founding family.
- name: Thin upper lip vermilion
  phenotype_term:
    preferred_term: Thin upper lip vermilion
    term:
      id: HP:0000219
      label: Thin upper lip vermilion
  evidence:
  - reference: PMID:24907849
    reference_title: "Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "downturned mouth corners, thin upper vermillion border and"  # codespell:ignore-line
    explanation: >
      A thin upper vermilion border is a facial dysmorphic feature in the
      founding family.
- name: Protruding ears
  phenotype_term:
    preferred_term: Prominent ears
    term:
      id: HP:0000411
      label: Protruding ear
  evidence:
  - reference: PMID:24907849
    reference_title: "Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "prominent ears, bilateral 5th finger camptodactyly"
    explanation: >
      Prominent ears are a facial dysmorphic feature in the founding family.
- name: Camptodactyly of the fifth finger
  phenotype_term:
    preferred_term: Camptodactyly of the fifth finger
    term:
      id: HP:0009183
      label: Joint contracture of the 5th finger
  evidence:
  - reference: PMID:24907849
    reference_title: "Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "prominent ears, bilateral 5th finger camptodactyly"
    explanation: >
      Bilateral 5th-finger camptodactyly is a limb feature in the founding
      family.
  - reference: PMID:32737394
    reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: "Affected individuals we present did not exhibit synophrys, midface \nhypoplasia, kyphosis, 5th finger camptodactyly, short 4th metatarsals or limited \nknee mobility observed in the reported family"
    explanation: >
      The later cohort explicitly lacked 5th-finger camptodactyly, documenting
      inter-family phenotypic heterogeneity for this feature.
- name: Short 4th metatarsal
  phenotype_term:
    preferred_term: Short 4th metatarsal
    term:
      id: HP:0004689
      label: Short fourth metatarsal
  evidence:
  - reference: PMID:24907849
    reference_title: "Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "bilateral short 4th metatarsal bones, and limited knee mobility"
    explanation: >
      Bilateral short 4th metatarsal bones are a limb feature in the founding
      family.
  - reference: PMID:32737394
    reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: "Affected individuals we present did not exhibit synophrys, midface \nhypoplasia, kyphosis, 5th finger camptodactyly, short 4th metatarsals or limited \nknee mobility observed in the reported family"
    explanation: >
      The later cohort explicitly lacked short 4th metatarsals, documenting
      inter-family phenotypic heterogeneity for this feature.
- name: Overlapping toes
  phenotype_term:
    preferred_term: Overriding toes
    term:
      id: HP:0001845
      label: Overlapping toe
  evidence:
  - reference: PMID:24907849
    reference_title: "Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "He had bilateral short fourth metatarsal bones with overriding toes, bilateral proximal insertion of the thumbs and persistent fetal pads on fingers and toes."
    explanation: >
      Overriding toes were documented in the founding family.
- name: Prominent fingertip pads
  phenotype_term:
    preferred_term: Persistent fetal fingertip pads
    term:
      id: HP:0001212
      label: Prominent fingertip pads
  evidence:
  - reference: PMID:24907849
    reference_title: "Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "He had bilateral short fourth metatarsal bones with overriding toes, bilateral proximal insertion of the thumbs and persistent fetal pads on fingers and toes."
    explanation: >
      Persistent fetal pads on fingers and toes were documented in the founding
      family.
- name: Proximal placement of thumb
  phenotype_term:
    preferred_term: Bilateral proximal insertion of the thumbs
    term:
      id: HP:0009623
      label: Proximal placement of thumb
  evidence:
  - reference: PMID:24907849
    reference_title: "Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "He had bilateral short fourth metatarsal bones with overriding toes, bilateral proximal insertion of the thumbs and persistent fetal pads on fingers and toes."
    explanation: >-
      Bilateral proximal insertion of the thumbs was documented on physical
      examination in both affected brothers of the founding family.
- name: Kyphosis
  phenotype_term:
    preferred_term: Kyphosis
    term:
      id: HP:0002808
      label: Kyphosis
  evidence:
  - reference: PMID:24907849
    reference_title: "Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "kyphosis without scoliosis"
    explanation: >
      Mild kyphosis was documented on skeletal survey in the founding family.
  - reference: PMID:32737394
    reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: "Affected individuals we present did not exhibit synophrys, midface \nhypoplasia, kyphosis, 5th finger camptodactyly, short 4th metatarsals or limited \nknee mobility observed in the reported family"
    explanation: >
      The later cohort explicitly lacked kyphosis, documenting inter-family
      phenotypic heterogeneity for this feature.
- name: Limited knee mobility
  phenotype_term:
    preferred_term: Limited knee mobility
    term:
      id: HP:0005085
      label: Limited knee flexion/extension
  evidence:
  - reference: PMID:24907849
    reference_title: "Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "bilateral short 4th metatarsal bones, and limited knee mobility"
    explanation: >
      Limited knee mobility was documented bilaterally in the founding family.
  - reference: PMID:32737394
    reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: "Affected individuals we present did not exhibit synophrys, midface \nhypoplasia, kyphosis, 5th finger camptodactyly, short 4th metatarsals or limited \nknee mobility observed in the reported family"
    explanation: >
      The later cohort explicitly lacked limited knee mobility, documenting
      inter-family phenotypic heterogeneity for this feature.
- name: Facial dysmorphism
  description: >
    The later cohort (PMID:32737394) is reported to have facial dysmorphism, but
    with specific features differing from the founding family — its individuals
    explicitly lacked the founding family's synophrys and midface hypoplasia.
    This generic node carries that cohort-level dysmorphism claim; the specific
    facial features modeled elsewhere in this entry derive from the founding
    family (PMID:24907849).
  phenotype_term:
    preferred_term: Facial dysmorphism
    term:
      id: HP:0001999
      label: Abnormal facial shape
  evidence:
  - reference: PMID:32737394
    reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "delayed pubertal onset and facial dysmorphism"
    explanation: >
      The later cohort exhibited facial dysmorphism as a cohort-level feature,
      though with different specific features than the founding family.
- name: Delayed puberty
  phenotype_term:
    preferred_term: Delayed pubertal onset
    term:
      id: HP:0000823
      label: Delayed puberty
  evidence:
  - reference: PMID:32737394
    reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "delayed pubertal onset and facial dysmorphism"
    explanation: >
      Delayed pubertal onset is reported among the variable features of the
      disorder.
diagnosis:
- name: Reported Molecular Testing for Biallelic ZNF407 Variants
  description: >-
    Published families were identified through homozygosity mapping and/or
    exome sequencing, followed by segregation assessment of biallelic ZNF407
    variants in affected relatives where samples were available. These are the
    reported study workflows, not a formally established testing requirement;
    the literature does not establish a validated clinical scoring system or
    disease-specific functional assay.
  evidence:
  - reference: PMID:32737394
    reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "by exome sequencing identified homozygous ZNF407 c.2814_2816dup (p.Val939dup) in four affected members"
    explanation: >-
      Exome sequencing identified the homozygous variant in the largest
      published family.
  - reference: PMID:24907849
    reference_title: "Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The family was studied by homozygosity mapping, candidate gene mutation screening and whole Exome Next Generation Sequencing"
    explanation: >-
      The founding family was solved through homozygosity mapping followed by
      sequence analysis.
discussions:
- discussion_id: znf407_neural_mechanism_translation
  prompt: >-
    Does impaired ZNF407 zinc-finger or cofactor activity alter a specific
    transcriptional program in human neural development, and do the reported
    biallelic variants act through the same mechanism?
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  attaches_to:
  - pathophysiology#Predicted Impairment of ZNF407 Transcriptional-Regulatory Function
  - pathophysiology#Impaired Neurodevelopment
  - pathophysiology#Impaired Somatic Development
  rationale: >-
    Disease-specific functional evidence is computational structural modeling
    of one missense allele. The direct experimental evidence for ZFP407 cofactor
    activity comes from mouse adipocytes and does not test neural cells, human
    development, or patient alleles. The reported recessive alleles also span
    missense and in-frame changes, so a uniform complete-loss-of-function model
    cannot be assumed. Resolving the relevant partners, targets, cell types, and
    allelic effects is necessary before the proposed transcriptional chain can
    be treated as established.
  evidence:
  - reference: PMID:24907849
    reference_title: "Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome."
    supports: SUPPORT
    evidence_source: COMPUTATIONAL
    snippet: "The mutated gene product was studied by structural bioinformatics methods."
    explanation: >-
      The founding disease-specific functional analysis was computational
      rather than an assay in patient-derived neural cells.
  - reference: PMID:38781157
    reference_title: "Molecular regulation of PPARγ/RXRα signaling by the novel cofactor ZFP407."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "ZFP407 was found to interact with the PPARγ/RXRα protein complex in the nucleus of adipocytes"
    explanation: >-
      The experimental cofactor evidence comes from adipocytes and therefore
      directly supports the stated human-neural translation gap.
  proposed_experiments:
  - experiment_id: znf407_patient_neural_isogenic_series
    name: Patient-derived neural isogenic allelic series
    description: >-
      Compare patient-derived iPSC neural progenitors and neurons with
      CRISPR-corrected controls, and engineer representative reported alleles in
      a shared background. Measure ZNF407 abundance and localization, chromatin
      occupancy, protein partners, transcriptomic effects, neuronal maturation,
      and rescue after correction or wild-type complementation.
    readouts:
    - name: Allele-specific ZNF407 molecular and neurodevelopmental phenotypes with rescue
      target: "pathophysiology#Predicted Impairment of ZNF407 Transcriptional-Regulatory Function"
- discussion_id: znf407_natural_history_and_frequency
  prompt: >-
    What are the unbiased phenotype frequencies, developmental trajectories,
    adult outcomes, and genotype-phenotype relationships of biallelic ZNF407
    disorder?
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - phenotypes#Intellectual disability
  - phenotypes#Short stature
  - phenotypes#Microcephaly
  rationale: >-
    The core literature contains only nine affected individuals from four
    families. Most detailed physical findings come from two brothers, while the
    later abstract reports a heterogeneous seven-person expansion. This is too
    small and ascertainment-dependent to establish penetrance for variable
    findings, long-term progression, adult prognosis, or robust allelic
    correlations.
  evidence:
  - reference: PMID:24907849
    reference_title: "Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "both affected\nindividuals are males"
    explanation: >-
      The founding report contributes detailed observations from only two
      affected individuals in one family.
  - reference: PMID:32737394
    reference_title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "five members of a consanguineous Pakistani family (Family I) plus two affected children from families of different ethnic origins"
    explanation: >-
      The later report adds seven affected individuals across three families,
      leaving natural history and unbiased frequencies unresolved.
  proposed_experiments:
  - experiment_id: znf407_international_natural_history_registry
    name: Genotype-first longitudinal natural-history cohort
    description: >-
      Assemble an international, genotype-first cohort with harmonized HPO
      phenotyping, developmental assessments, growth and pubertal trajectories,
      ophthalmologic and audiologic evaluations, and longitudinal follow-up.
    readouts:
    - name: Age-stratified phenotype frequencies and developmental trajectories
      target: "phenotypes#Intellectual disability"
references:
- reference: PMID:24907849
  title: "Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome."
- reference: PMID:32737394
  title: "Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism."
- reference: PMID:23195952
  title: "Balanced translocation t(3;18)(p13;q22.3) and points mutation in the ZNF407 gene detected in patients with both moderate non-syndromic intellectual disability and autism."
- reference: PMID:38781157
  title: "Molecular regulation of PPARγ/RXRα signaling by the novel cofactor ZFP407."
📚

References & Deep Research

References

4
PMID:24907849
Mutations in zinc finger 407 [ZNF407] cause a unique autosomal recessive cognitive impairment syndrome.
No top-level findings curated for this source.
PMID:32737394
Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism.
No top-level findings curated for this source.
PMID:23195952
Balanced translocation t(3;18)(p13;q22.3) and points mutation in the ZNF407 gene detected in patients with both moderate non-syndromic intellectual disability and autism.
No top-level findings curated for this source.
PMID:38781157
Molecular regulation of PPARγ/RXRα signaling by the novel cofactor ZFP407.
No top-level findings curated for this source.

Deep Research

1
Falcon ▸
ZNF407-Related Neurodevelopmental Disorder: Research Report
Edison Scientific Literature 17 citations 2026-08-01T18:20:31.120062

ZNF407-Related Neurodevelopmental Disorder: Research Report

Executive summary and evidence limits

ZNF407-related neurodevelopmental disorder is an ultra-rare, autosomal-recessive Mendelian disorder caused by biallelic pathogenic variants in ZNF407, which encodes a large C2H2 zinc-finger transcriptional regulator. Its best-supported clinical features are developmental delay/intellectual disability, severe speech and motor delay, postnatal short stature or failure to thrive, hypotonia, ocular abnormalities, characteristic facial dysmorphism, and variable distal-limb or orthopedic abnormalities. The foundational evidence is a 2014 report of two affected brothers; a 2020 publication expanded the allelic and phenotypic spectrum. Open Targets currently maps ZNF407 to MONDO:0859198, “short stature, impaired intellectual development, microcephaly, hypotonia, and ocular anomalies,” citing PMID 24907849, PMID 32737394, and newer evidence including PMID 39024449. This MONDO term is presently the most specific retrievable identifier (kambouris2014mutationsinzinc pages 1-2, OpenTargets Search: -ZNF407).

The evidence base remains very small. Exact phenotype frequencies below therefore refer primarily to the original two-person family and should not be interpreted as population-level estimates. No disease-specific guideline, biomarker, natural-history registry, interventional trial, or validated neural animal/iPSC model was identified.

domain evidence-backed finding suggested ontology terms/IDs evidence type/strength
disease label ZNF407-related neurodevelopmental disorder is an ultra-rare Mendelian disorder associated with biallelic pathogenic variation in ZNF407; Open Targets links ZNF407 to MONDO:0859198 short stature, impaired intellectual development, microcephaly, hypotonia, and ocular anomalies (OpenTargets Search: -ZNF407) MONDO:0859198 Human disease-gene aggregation + primary case report; moderate for disease validity, limited cohort size
inheritance Available human evidence supports autosomal recessive inheritance with affected individuals homozygous for ZNF407 variants in a consanguineous family; unaffected relatives/carrier fetus were heterozygous or unaffected (kambouris2014mutationsinzinc pages 1-2, kambouris2014mutationsinzinc pages 2-4) Autosomal recessive inheritance; biallelic ZNF407 Primary human segregation evidence; strong within one pedigree
causal gene/variant Foundational report identified ZNF407 c.C5054G (p.S1685W) at 18q23, absent from public variant databases available at the time and from 400 ethnically matched control chromosomes; later literature cited additional biallelic ZNF407 cases and other missense alleles (kambouris2014mutationsinzinc pages 1-2, kambouris2014mutationsinzinc pages 6-7, kambouris2014mutationsinzinc pages 4-6) ZNF407 Primary human molecular evidence for p.S1685W; expanded allelic spectrum supported by secondary/database evidence
neurodevelopmental phenotype Severe developmental/cognitive disability was present in both reported brothers: delayed sitting, delayed independent walking, delayed/very limited speech, and lack of toilet training at assessment (kambouris2014mutationsinzinc pages 2-4) HP:0001263 Global developmental delay; HP:0001249 Intellectual disability; HP:0000750 Delayed speech and language development; HP:0001270 Motor delay Primary human clinical evidence; strong for original family
growth phenotype Both boys had postnatal growth restriction with height below the 3rd percentile and weight around the 3rd percentile; failure-to-thrive was emphasized in the abstract (kambouris2014mutationsinzinc pages 1-2, kambouris2014mutationsinzinc pages 2-4) HP:0004322 Short stature; HP:0001508 Failure to thrive Primary human clinical evidence; strong for 2/2 original cases
neurologic phenotype Hypotonia with exaggerated deep tendon reflexes was reported in both affected individuals; gait was awkward with bent knees in the older child (kambouris2014mutationsinzinc pages 2-4) HP:0001252 Hypotonia; HP:0006808 Increased deep tendon reflexes; HP:0002317 Unsteady gait Primary human clinical evidence; strong for original family
ocular phenotype Bilateral ptosis, epicanthic folds, and strabismus were reported; later disease naming also includes ocular anomalies (kambouris2014mutationsinzinc pages 2-4, OpenTargets Search: -ZNF407) HP:0000508 Ptosis; HP:0000286 Epicanthus; HP:0000486 Strabismus Primary human clinical evidence + curated disease aggregation; moderate
craniofacial phenotype Recurrent facial dysmorphism included synophrys, midface hypoplasia, downturned mouth corners, thin upper vermilion border, and prominent ears with overfolding/absent lobules (kambouris2014mutationsinzinc pages 2-4, kambouris2014mutationsinzinc pages 1-2) HP:0000664 Synophrys; HP:0000340 Short philtrum/not established; HP:0011800 Midface retrusion; HP:0002714 Downturned corners of mouth; HP:0010807 Thin upper vermilion border; HP:0000411 Prominent ear Primary human clinical evidence; moderate-strong
musculoskeletal phenotype Skeletal findings included bilateral 5th-finger camptodactyly, short 4th metatarsals with overriding toes, proximal thumb insertion, persistent fetal pads, limited knee mobility/awkward bent-knee gait, femoral subluxation, dysplastic acetabulum, and mild kyphosis (kambouris2014mutationsinzinc pages 1-2, kambouris2014mutationsinzinc pages 2-4) HP:0004209 Camptodactyly of finger; HP:0010511 Short metatarsal; HP:0001841 2-4 toe syndactyly/not established; HP:0002808 Kyphosis; HP:0001382 Joint hypermobility/limited mobility not firmly assigned Primary human clinical evidence; moderate
neuroimaging and ancillary testing Brain MRI was normal in both reported cases; karyotype, array CGH, echocardiogram, abdominal ultrasound, and hearing testing were normal where performed (kambouris2014mutationsinzinc pages 2-4) Normal brain MRI; no specific ontology term required Primary human diagnostic evidence; moderate
molecular mechanism The p.S1685W substitution lies in the linker between zinc fingers 18 and 19, disrupts an H-bond with E1683, increases linker flexibility, and is predicted to reduce zinc finger-DNA complex formation and downstream transcriptional control during fetal brain development (kambouris2014mutationsinzinc pages 1-2, kambouris2014mutationsinzinc pages 4-6, kambouris2014mutationsinzinc pages 6-7) GO:0003700 DNA-binding transcription factor activity; GO:0006355 regulation of DNA-templated transcription Primary in silico structural modeling anchored to human variant; moderate mechanistic evidence
gene/protein biology ZNF407 is a multi-zinc-finger transcription factor with nuclear relevance; mRNA/protein expression was reported across multiple tissues including adult, embryonic, and fetal CNS/PNS in the 2014 paper (kambouris2014mutationsinzinc pages 6-7) GO:0005634 nucleus; GO:0003677 DNA binding Mixed evidence (human expression/database statements); moderate
ortholog/functional biology Mouse Zfp407 is nuclear in adipocytes, participates in a PPARγ/RXRα complex, and showed 7,313 ChIP-seq peaks, with ~50.4% overlap with PPARγ peaks and 64.8% overlap among the top 1,000 peaks; this supports transcription-factor function but is not a disease-specific neural model (charrier2024molecularregulationof pages 1-2, charrier2024molecularregulationof pages 2-4, charrier2024molecularregulationof pages 5-7) GO:0005634 nucleus; GO:0006351 transcription, DNA-templated Non-disease ortholog/cellular evidence; supportive but indirect for neurodevelopmental disorder
diagnosis Best-supported diagnosis is genomic: exome/genome sequencing in patients with syndromic developmental delay/intellectual disability, followed by segregation testing; homozygosity mapping was informative in the consanguineous family, while karyotype/CMA/MRI were non-diagnostic in the original cases (kambouris2014mutationsinzinc pages 2-4, kambouris2014mutationsinzinc pages 1-2) HP:0001263 Global developmental delay; ZNF407 single-gene analysis/WES Primary human diagnostic workflow evidence; moderate
management No disease-specific therapy or trials were identified. Current care is supportive: developmental therapies, rehabilitation, educational support, orthopedic monitoring/intervention as needed, and clinical genetics follow-up with reproductive counseling (kambouris2014mutationsinzinc pages 2-4) Supportive care; genetic counseling Inference from phenotype + absence of disease-specific interventional evidence; low-directness but clinically standard
prevention/family planning Because evidence supports autosomal recessive inheritance, recurrence-risk counseling, carrier testing of relatives, prenatal diagnosis, and possibly preimplantation genetic testing are relevant where a familial pathogenic variant is known; prenatal testing identified an unaffected heterozygous fetus in the original pedigree (kambouris2014mutationsinzinc pages 2-4) Genetic counseling; carrier testing; prenatal diagnosis Primary pedigree evidence + standard Mendelian practice; moderate
epidemiology No robust prevalence or incidence estimates were identified; evidence indicates an ultra-rare disorder with only a very small number of published families/patients (kambouris2014mutationsinzinc pages 1-2, OpenTargets Search: -ZNF407) Rare disease Sparse human literature; low
prognosis Long-term natural history, survival, adult outcomes, penetrance, and genotype-phenotype correlations remain poorly defined; available childhood data suggest chronic, lifelong neurodevelopmental disability without evidence of neurodegeneration in the original report (kambouris2014mutationsinzinc pages 2-4) Chronic neurodevelopmental disorder Very limited longitudinal evidence; low
major evidence gaps Major gaps include: lack of large cohorts, no validated prevalence estimates, no standardized diagnostic criteria, no disease-specific biomarkers, no neural iPSC/animal disease model, no treatment trials, and limited access to the 2020 expanded cohort details despite bibliographic confirmation (OpenTargets Search: -ZNF407) Evidence gap annotation Strong confidence in absence of evidence from searches; low for any omitted unpublished data

Table: This table condenses the strongest currently retrievable evidence for ZNF407-related neurodevelopmental disorder into knowledge-base-ready findings. It highlights core disease definition, inheritance, phenotype, mechanism, diagnostic approach, management, and the most important current evidence gaps.

1. Disease information

Definition and identifiers

The disorder is a syndromic neurodevelopmental condition in which biallelic ZNF407 dysfunction disrupts transcriptional regulation during development. The original designation was “autosomal recessive cognitive impairment syndrome”; subsequent usage includes “ZNF407-related neurodevelopmental disorder,” “biallelic ZNF407 neurodevelopmental disorder,” and the phenotype-based title “short stature, impaired intellectual development, microcephaly, hypotonia, and ocular anomalies.” The 2014 study described it as a “unique autosomal recessive cognitive impairment syndrome” (kambouris2014mutationsinzinc pages 1-2).

  • MONDO: MONDO:0859198.
  • Gene: ZNF407, zinc finger protein 407; Ensembl ENSG00000215421.
  • Cytogenetic location: 18q23.
  • OMIM/Orphanet: A separate confidently verified disease-number entry was not available in the retrieved evidence. The 2014 report was published in Orphanet Journal of Rare Diseases, but this does not itself establish an ORPHA identifier.
  • ICD-10/ICD-11: No disease-specific code was identified. Coding would ordinarily use broader intellectual-developmental-disorder, developmental-delay, hypotonia, short-stature, or congenital-anomaly categories.
  • MeSH: No dedicated disease heading was identified; broader headings include Intellectual Disability, Neurodevelopmental Disorders, and Zinc Finger Proteins.

Evidence is mainly aggregated disease-level information derived from published, deeply phenotyped individual patients and families, rather than EHR-scale cohorts. Open Targets provides an aggregated gene–disease association supported by literature and ClinVar records (OpenTargets Search: -ZNF407).

Key primary publications

  1. Kambouris et al., Orphanet Journal of Rare Diseases, published June 2014, DOI 10.1186/1750-1172-9-80, PMID 24907849. Verbatim abstract conclusion: “ZNF407 is a transcription factor with an essential role in brain development” (kambouris2014mutationsinzinc pages 1-2).
  2. Zahra et al., Journal of Human Genetics, published online July 2020, DOI 10.1038/s10038-020-0812-0, PMID 32737394. Its title documents the expanded phenotype: “Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism” (OpenTargets Search: -ZNF407).
  3. Charrier et al., PLOS ONE, published May 23, 2024, DOI 10.1371/journal.pone.0294003. This is mechanistic ortholog evidence in adipocytes, not a clinical disease study (charrier2024molecularregulationof pages 1-2).

2. Etiology

Causal factors and genetic risk

The established cause is germline biallelic ZNF407 variation, with autosomal-recessive segregation. In the original consanguineous Qatari family, both affected brothers were homozygous for c.5054C>G, p.(Ser1685Trp) as reported in the study’s transcript notation. The variant segregated with disease; an unaffected fetus identified by amniocentesis was heterozygous and remained unaffected after birth. The variant was absent from the then-current 1000 Genomes/dbSNP resources and from 400 ethnically matched control chromosomes (kambouris2014mutationsinzinc pages 4-6, kambouris2014mutationsinzinc pages 2-4).

Two heterozygous de novo variants, p.(Tyr460Cys) and p.(Pro1195Ala), had been observed independently in patients with intellectual impairment, and a translocation disrupting intron 3 had been associated with reduced isoform-1 transcript, intellectual impairment, and autism. These observations support dosage sensitivity or broader allelic heterogeneity, but they do not establish that heterozygous variants cause the same recessive syndrome (kambouris2014mutationsinzinc pages 6-7).

Consanguinity increases the probability that two carriers of the same rare allele have an affected child, but it is not itself a biological cause. Family history of an affected sibling is the principal identifiable risk factor. For two heterozygous parents, the standard per-pregnancy probabilities are 25% affected, 50% carrier, and 25% unaffected/non-carrier, assuming complete penetrance of the familial pathogenic genotype.

Environmental, infectious, and protective factors

No environmental toxin, lifestyle exposure, infectious agent, maternal-age effect, sex-specific susceptibility, or gene–environment interaction has been demonstrated. The original pregnancies and deliveries were described as uneventful, supporting a constitutional genetic rather than acquired cause (kambouris2014mutationsinzinc pages 2-4). No protective allele, diet, medication, or exposure has been validated. Avoiding consanguinity can lower the chance that partners share the same rare recessive allele at a population level, but it is not disease-specific biological protection.

3. Phenotypes

Core phenotype and frequencies in the original family

Both reported brothers had severe developmental/cognitive disability, severe motor and speech delay, postnatal growth restriction, hypotonia with brisk reflexes, ptosis, epicanthal folds, synophrys, strabismus, midface hypoplasia, downturned mouth corners, a thin upper vermilion, and prominent abnormal ears. Thus, these findings were 2/2 in the original cohort, but the denominator is too small for reliable syndrome-wide frequency estimates (kambouris2014mutationsinzinc pages 2-4).

  • Developmental delay/intellectual disability: HP:0001263, HP:0001249. The older boy sat at 3 years, walked at 4–5 years, began very limited speech at 8 years, and had a Leiter-R Brief IQ of 36. The younger boy, aged 5, could sit but only attempted to pull to stand, babbled infrequently, and had severe impairment on the Vineland scale. Neither was toilet trained at assessment. Severity was severe and functionally consequential (kambouris2014mutationsinzinc pages 2-4).
  • Motor delay: HP:0001270; delayed walking: HP:0002066. Pediatric onset, severe, apparently chronic.
  • Speech/language delay: HP:0000750; severely limited speech: HP:0001344. Pediatric onset and severe.
  • Hypotonia: HP:0001252; hyperreflexia: HP:0001347. Both were present in both brothers, indicating mixed central motor findings rather than a proven peripheral neuromuscular disorder (kambouris2014mutationsinzinc pages 2-4).
  • Short stature: HP:0004322; failure to thrive: HP:0001508. At 11 years, height was 124 cm, below the third percentile, and weight 27 kg, at the third percentile. At 5 years, height was 95 cm, below the third percentile, and weight 15 kg, at the third percentile. Birth measurements were reportedly normal, suggesting postnatal growth restriction (kambouris2014mutationsinzinc pages 2-4).
  • Microcephaly: HP:0000252. Head circumference was normal in the two original patients, while the 2020 disease description explicitly reports variable microcephaly. It is therefore not obligatory (kambouris2014mutationsinzinc pages 2-4, OpenTargets Search: -ZNF407).
  • Ptosis: HP:0000508; epicanthus: HP:0000286; strabismus: HP:0000486. Bilateral and childhood-onset in both original cases.
  • Facial dysmorphism: synophrys HP:0000664, midface retrusion/hypoplasia HP:0011800, downturned mouth corners HP:0002714, thin upper lip vermilion HP:0000219, prominent ears HP:0000411, and abnormal pinnae/earlobes. These are diagnostic clues, not pathognomonic findings (kambouris2014mutationsinzinc pages 1-2).
  • Camptodactyly: HP:0012385, especially fifth finger; short fourth metatarsal: HP:0010743; overriding toes: HP:0001845; persistent fetal pads: HP:0011831; proximal thumb insertion and limited knee mobility were also described (kambouris2014mutationsinzinc pages 2-4).
  • Orthopedic abnormalities: femoral/hip subluxation, acetabular dysplasia, and mild kyphosis occurred in the younger child; HP:0002827, HP:0008807, and HP:0002808 may be considered after patient-level verification (kambouris2014mutationsinzinc pages 2-4).
  • Gait abnormality: HP:0001288. The older child walked awkwardly with bent knees.

Negative or variable findings

Brain MRI was structurally normal in both brothers. Karyotype, array-CGH, echocardiography, and abdominal ultrasonography were normal; auditory evoked potentials were normal in the older child. No consistent seizures, biochemical abnormality, immune dysfunction, metabolic crisis, or organ failure was reported in the foundational family (kambouris2014mutationsinzinc pages 2-4).

Quality-of-life impact

No EQ-5D, SF-36, PROMIS, or disease-specific QoL study exists. Nevertheless, the documented severe adaptive impairment, delayed mobility, minimal speech, and absent toilet independence imply major effects on communication, self-care, education, mobility, and caregiver burden. This is a clinical inference from functional data, not a validated QoL measurement (kambouris2014mutationsinzinc pages 2-4).

4. Genetic and molecular information

Gene and protein

ZNF407 encodes a large C2H2 zinc-finger protein. The 2014 canonical annotation described a 2,248-amino-acid, approximately 247-kDa protein containing 22 zinc fingers and three alternatively spliced isoforms. Isoform 3 lacks zinc fingers 18–22; consequently, p.S1685W affects two of the three described isoforms (kambouris2014mutationsinzinc pages 4-6).

Suggested annotations include GO:0003700 DNA-binding transcription factor activity, GO:0003677 DNA binding, GO:0006355 regulation of DNA-templated transcription, GO:0005634 nucleus, and GO:0006357 regulation of transcription by RNA polymerase II. These should be treated as functional annotation suggestions rather than disease-specific experimentally validated GO assertions.

Variant interpretation

The foundational p.S1685W allele is a germline homozygous missense variant. Evidence supporting pathogenicity includes segregation, rarity, conservation, damaging in-silico predictions, location in a functionally constrained zinc-finger linker, and structural modeling. No patient-derived transcriptional assay was reported, so the precise functional class is best described as predicted loss or severe impairment of DNA-binding/transcriptional-regulatory function, not definitively proven complete loss of function (kambouris2014mutationsinzinc pages 4-6, kambouris2014mutationsinzinc pages 6-7).

Current ClinVar classifications must be checked against the exact transcript and genome build at implementation time. Historical absence from databases should not be substituted for a current gnomAD frequency. The retrieved evidence did not provide a current gnomAD allele count or a comprehensive list of the 2020 cohort’s HGVS variants.

Structural variation

A translocation breakpoint in intron 3 reportedly reduced ZNF407 isoform-1 transcript and was associated with nonsyndromic intellectual impairment and autism. Larger 18q23 deletions encompassing ZNF407 and neighboring genes have broader, contiguous-gene phenotypes, including congenital aural atresia; these should not be equated with the biallelic single-gene disorder (kambouris2014mutationsinzinc pages 6-7).

No validated modifier gene, protective allele, disease-specific DNA-methylation episignature, histone abnormality, or recurrent founder variant was identified.

5. Environmental information

No causal or modifying environmental exposure is established. Smoking, alcohol, diet, exercise, pollution, occupational exposures, radiation, and infection have no demonstrated role in this Mendelian syndrome. Open Targets lists other statistical associations involving ZNF407, including smoking behavior, but these are distinct traits and do not show that smoking contributes to the recessive neurodevelopmental disorder (OpenTargets Search: -ZNF407).

6. Mechanism and pathophysiology

Disease-specific proposed causal chain

  1. A biallelic damaging ZNF407 allele alters a conserved C2H2 zinc-finger region.
  2. For p.S1685W, substitution in the linker between zinc fingers 18 and 19 abolishes an H-bond between Ser1685 and Glu1683.
  3. Modeling predicts increased linker flexibility and poorer geometric positioning of adjacent fingers on DNA.
  4. This is predicted to lower DNA-binding probability and compromise downstream zinc-finger function.
  5. Altered transcription of ZNF407 target genes during fetal brain and somatic development is proposed to disturb neurodevelopment, growth, craniofacial patterning, ocular development, and musculoskeletal development.
  6. The downstream clinical result is developmental/intellectual disability with hypotonia, growth restriction, dysmorphism, and variable congenital anomalies (kambouris2014mutationsinzinc pages 1-2, kambouris2014mutationsinzinc pages 4-6, kambouris2014mutationsinzinc pages 6-7).

Steps 1–3 have human genetic and structural-model support. Steps 4–6 remain biologically plausible but incompletely validated because the relevant neural target genes and cell types have not been experimentally defined.

Cellular localization and 2024 mechanistic development

The 2014 report noted ZNF407 mRNA and protein expression across many tissues, including adult, embryonic, and fetal central and peripheral nervous systems, with nuclear and cytoplasmic staining. Tissue-specific expression of the affected isoforms was unknown (kambouris2014mutationsinzinc pages 6-7).

A 2024 study of the mouse ortholog Zfp407 provided stronger biochemical evidence for transcriptional-cofactor function, albeit in adipocytes rather than neurons. ZFP407 localized to the nucleus, interacted with endogenous PPARγ/RXRα complexes, and produced 7,313 ChIP-seq peaks in differentiated 3T3-L1 cells. Overall, 50.4% of ZFP407 peaks overlapped PPARγ peaks, increasing to 64.8% among the top 1,000 peaks. The authors concluded that ZFP407 likely regulates PPARγ through direct complex formation. GEO accession: GSE245861 (charrier2024molecularregulationof pages 4-5, charrier2024molecularregulationof pages 1-2, charrier2024molecularregulationof pages 5-7).

This 2024 work also supports roles in adipocyte differentiation, glucose transport, and lipid metabolism: earlier mouse studies summarized therein found that Zfp407 overexpression improved glucose homeostasis, whereas deficiency caused lipodystrophy and worsened insulin resistance. These findings are relevant to general protein biology but do not establish metabolic disease as a feature of affected children (charrier2024molecularregulationof pages 2-4).

Suggested process, cell, and anatomy terms

  • GO: GO:0006355 regulation of DNA-templated transcription; GO:0007399 nervous system development; GO:0007417 central nervous system development; GO:0048666 neuron development; GO:0005634 nucleus.
  • CL: CL:0000540 neuron and CL:0000047 neuronal stem cell may be used as hypotheses for developmental mechanism; no disease-specific cell-type experiment validates them. CL:0000136 adipocyte is directly supported for the ortholog biochemical work.
  • UBERON: UBERON:0000955 brain, UBERON:0001017 central nervous system, UBERON:0000019 camera-type eye, UBERON:0002107 liver or adipose annotations should not be assigned as diseased tissues without patient evidence.

No disease-specific neuronal transcriptome, proteome, metabolome, lipidome, single-cell atlas, spatial-transcriptomic study, CRISPR screen, or multi-omics integration was identified. No immune, inflammatory, degenerative, oxidative-stress, or metabolic-tissue-damage mechanism is established.

7. Anatomical structures affected

The primary affected system is the nervous system, inferred from severe neurodevelopmental dysfunction despite normal conventional MRI. Relevant sites are the brain/CNS (UBERON:0000955; UBERON:0001017), but no reproducible regional lesion or lateralization is known. Functional disruption likely occurs at cellular or circuit levels rather than producing a gross structural malformation detectable by routine MRI (kambouris2014mutationsinzinc pages 2-4).

Secondary developmental involvement includes the eyes/extraocular apparatus, craniofacial structures, distal limbs, hip/acetabulum, knees, and axial skeleton. Findings are generally bilateral—ptosis, epicanthi, strabismus, short fourth metatarsals, and some hand abnormalities—without known cerebral lateralization. At the subcellular level, the nucleus is the best-supported compartment for transcriptional function (GO:0005634), although older tissue staining also reported some cytoplasmic positivity (charrier2024molecularregulationof pages 5-7, kambouris2014mutationsinzinc pages 6-7).

8. Temporal development

Onset is congenital or early pediatric and likely begins prenatally at the molecular level. Birth growth parameters can be normal, while developmental delays and postnatal short stature become evident in infancy or childhood. The two original patients had severe milestone delay by early childhood (kambouris2014mutationsinzinc pages 2-4).

The available evidence is compatible with a chronic, lifelong developmental encephalopathy, not an acute, episodic, relapsing, or proven neurodegenerative condition. No formal disease stages, progression rate, remission pattern, or adult natural history have been defined. Early childhood is the most plausible intervention window for speech, motor, feeding, educational, and adaptive therapies because neurodevelopmental plasticity is greatest then, but no ZNF407-specific critical-period study exists.

9. Inheritance and population

Inheritance is autosomal recessive. Segregation in the original consanguineous family was strong: two affected homozygous brothers, heterozygous parents, and an unaffected heterozygous fetus/child (kambouris2014mutationsinzinc pages 2-4). Penetrance appears high for the reported biallelic genotype but cannot be quantified. Expressivity is variable, particularly for microcephaly and orthopedic findings. No anticipation is expected or reported. Germline mosaicism remains theoretically possible but has not been documented.

Prevalence, incidence, carrier frequency, founder effect, geographic distribution, and sex ratio are unknown. Published families include Middle Eastern/South Asian ancestry and consanguinity, but there is no evidence that the disorder is biologically restricted to any ethnicity. Both original patients were male; this is insufficient to infer sex bias. The absence of population estimates and the tiny literature indicate an ultra-rare disorder rather than a calculable prevalence (kambouris2014mutationsinzinc pages 1-2, OpenTargets Search: -ZNF407).

10. Diagnostics

Recommended approach

Diagnosis requires identification of biallelic pathogenic/likely pathogenic ZNF407 variants compatible with phenotype and recessive inheritance.

  1. Perform clinical assessment including growth, head circumference, developmental and adaptive testing, neurologic/ophthalmologic examination, dysmorphology, and musculoskeletal assessment.
  2. Use trio whole-exome sequencing or whole-genome sequencing, or a comprehensive neurodevelopmental/intellectual-disability panel that includes ZNF407. WGS is preferable when exome sequencing is negative and a deep-intronic, regulatory, or structural variant is suspected.
  3. Confirm candidate variants and phase by parental segregation testing. Homozygosity mapping is particularly useful in consanguineous families.
  4. Apply current ACMG/AMP criteria with transcript-specific HGVS nomenclature and current ClinVar/gnomAD review.
  5. Use chromosomal microarray to identify pathogenic CNVs or 18q abnormalities, but recognize that CMA will generally not detect single-nucleotide ZNF407 variants. The original patients had normal array-CGH and karyotypes (kambouris2014mutationsinzinc pages 2-4, kambouris2014mutationsinzinc pages 1-2).

Single-gene sequencing is reasonable for familial cascade/prenatal testing or when the phenotype and family history are highly specific. Karyotyping or FISH is reserved for suspected balanced rearrangement; mitochondrial and repeat-expansion tests are not specifically indicated. No diagnostic enzyme assay, metabolite, circulating protein, histopathologic signature, EEG pattern, or MRI biomarker is known.

RNA sequencing could theoretically demonstrate aberrant splicing or reduced transcript from splice/structural variants, but there is no validated disease assay or established accessible tissue. No methylation episignature or liquid biopsy is available.

Differential diagnosis

Differentials include other recessive zinc-finger transcription-factor disorders—especially ZNF142-related disorder—as well as Coffin–Siris/BAF-complex disorders, Kabuki syndrome, KBG syndrome, White–Sutton syndrome, 18q deletion syndrome, congenital disorders with ptosis and camptodactyly, and nonspecific syndromic intellectual disability. Distinguishing evidence is the biallelic ZNF407 genotype; normal MRI and normal routine metabolic/cytogenetic investigations do not exclude the condition.

No population newborn screening is available. Cascade carrier testing is appropriate after establishing familial pathogenic variants.

11. Outcome and prognosis

No survival curve, mortality rate, life-expectancy estimate, or adult-outcome cohort exists. The original affected children were alive at ages 5 and 11. No life-threatening visceral involvement was identified in that family, but the sample is too small to conclude that life expectancy is normal (kambouris2014mutationsinzinc pages 2-4).

Expected morbidity centers on intellectual/adaptive disability, communication impairment, delayed or abnormal mobility, dependence in activities of daily living, short stature, visual/ocular problems, and orthopedic complications. Full neurodevelopmental recovery is unlikely, but functional gains may occur with therapy. No molecular prognostic biomarker or validated genotype–phenotype predictor exists. Variant class, residual isoform function, early developmental severity, mobility, feeding, and orthopedic burden are reasonable clinical considerations but remain unvalidated prognostic factors.

12. Treatment

There is no approved disease-modifying therapy, gene therapy, RNA therapy, cell therapy, or genotype-specific pharmacotherapy. The ClinicalTrials.gov search identified no relevant ZNF407 trial. Treatment is therefore multidisciplinary and symptom-directed:

  • early developmental intervention and individualized education;
  • speech-language therapy, including augmentative and alternative communication;
  • physical therapy for hypotonia, delayed gait, contracture prevention, and balance;
  • occupational therapy for fine motor skills, self-care, and adaptive equipment;
  • ophthalmologic management of ptosis, strabismus, and refractive/visual problems;
  • orthopedic surveillance for hip subluxation/dysplasia, kyphosis, camptodactyly, and limited joint mobility, with bracing or surgery when clinically indicated;
  • nutritional and growth assessment, with feeding support if needed;
  • standard symptomatic management of seizures, sleep, behavioral symptoms, constipation, or pain if these occur—none is a proven defining feature or ZNF407-specific drug target;
  • clinical-genetics follow-up and family support.

Suggested NCIT intervention terms include Genetic Counseling, Physical Therapy, Occupational Therapy, Speech and Language Therapy, Supportive Care, and procedure-specific orthopedic or ophthalmic surgery terms. Exact NCIT codes should be validated against the current thesaurus release before ingestion. No response rates, adverse-event profiles, pharmacogenomic recommendations, or treatment algorithm have been published.

The adipocyte PPARγ/RXRα results should not be interpreted as evidence for thiazolidinediones in this disorder. The 2024 study was mechanistic and non-neural, and PPARγ agonists have recognized systemic adverse effects (charrier2024molecularregulationof pages 1-2, charrier2024molecularregulationof pages 2-4).

13. Prevention

Primary prevention by lifestyle change or vaccination is not applicable. For known carrier couples, reproductive options include genetic counseling, partner/carrier testing, preimplantation genetic testing for monogenic disease, chorionic-villus sampling or amniocentesis for targeted prenatal diagnosis, and use of donor gametes. The original study demonstrated practical prenatal diagnosis: amniocentesis identified a heterozygous fetus who was unaffected after birth (kambouris2014mutationsinzinc pages 2-4).

Secondary prevention consists of early molecular diagnosis and prompt developmental intervention. Tertiary prevention includes surveillance and therapy to reduce contractures, hip complications, communication deprivation, feeding/growth problems, and preventable visual impairment. Population carrier or newborn screening is not currently justified by available evidence.

14. Other species and natural disease

The human gene has a mouse ortholog, Zfp407; relevant taxonomy includes Homo sapiens NCBI Taxon 9606 and Mus musculus NCBI Taxon 10090. No naturally occurring veterinary ZNF407 syndrome, affected breed, zoonosis, or cross-species transmission phenomenon was identified. The condition is genetic and noninfectious, so zoonotic potential is not applicable.

Ortholog conservation supports a conserved transcriptional-regulatory function, but available mouse work primarily concerns adipocyte metabolism rather than a spontaneous neurodevelopmental phenotype (charrier2024molecularregulationof pages 4-5, charrier2024molecularregulationof pages 5-7).

15. Model organisms

Available experimental systems

The clearest experimental system is mouse 3T3-L1 adipocytes expressing ZFP407. Co-immunoprecipitation, subcellular fractionation, reporter assays, mutagenesis, and ChIP-seq establish nuclear localization, PPARγ/RXRα complex participation, and extensive chromatin occupancy. The ChIP-seq dataset is available as GEO GSE245861 (charrier2024molecularregulationof pages 4-5, charrier2024molecularregulationof pages 1-2, charrier2024molecularregulationof pages 5-7).

Mouse gain- and loss-of-function studies summarized in the 2024 paper show improved glucose homeostasis with overexpression and lipodystrophy/insulin resistance with deficiency. These models are suitable for studying transcriptional cofactor function and metabolism but do not currently recapitulate the human intellectual-disability, ocular, craniofacial, or skeletal syndrome (charrier2024molecularregulationof pages 2-4).

Missing disease models and priorities

No validated Znf407 knock-in mouse carrying a human disease allele, neural conditional knockout, zebrafish model, Drosophila model, patient-derived iPSC neuron, cerebral organoid, or isogenic CRISPR model was identified. Priority models would include:

  1. patient-derived and CRISPR-corrected iPSC cortical neurons/organoids;
  2. p.S1685W knock-in mice or neural-progenitor conditional Zfp407 loss;
  3. neuronal ChIP-seq/CUT&RUN and RNA-seq to identify direct developmental targets;
  4. single-cell developmental profiling to identify vulnerable neural lineages;
  5. rescue experiments comparing major human isoforms.

These would test the proposed chain from impaired zinc-finger DNA binding to altered neurodevelopmental transcription and clinical phenotype.

Knowledge-base conclusions

The disease–gene relationship is supported by recessive human segregation, recurrence in later biallelic cases, variant rarity, and mechanistic plausibility. Nevertheless, pathogenic mechanisms remain incompletely established because the strongest disease-specific functional evidence is structural modeling rather than patient-derived neural experimentation. Phenotypic frequencies, penetrance, prognosis, and treatment effects should therefore be labeled limited/unknown, not inferred from two original patients. The 2024 ZFP407 work significantly advances understanding of protein function, but its adipocyte context makes it indirect evidence for neurodevelopmental pathophysiology (charrier2024molecularregulationof pages 1-2, charrier2024molecularregulationof pages 5-7).

Evidence-source classification

  • Human clinical/genetic: Kambouris et al. 2014, PMID 24907849; Zahra et al. 2020, PMID 32737394.
  • Structural computational: homology modeling of p.S1685W in Kambouris et al. 2014.
  • Cellular/model-organism: mouse ZFP407 experiments in 3T3-L1 adipocytes, Charrier et al. 2024.
  • Aggregated database: Open Targets/ClinVar-linked disease associations, including MONDO:0859198.
  • Not available: epidemiologic cohorts, longitudinal natural history, neural disease models, omics biomarkers, treatment trials, and disease-specific clinical guidelines.

References

  1. (kambouris2014mutationsinzinc pages 1-2): Marios Kambouris, Rachid C Maroun, Tawfeg Ben-Omran, Yasser Al-Sarraj, Khaoula Errafii, Rehab Ali, Hala Boulos, Patrick A Curmi, and Hatem El-Shanti. Mutations in zinc finger 407 [znf407] cause a unique autosomal recessive cognitive impairment syndrome. Orphanet Journal of Rare Diseases, 9:80-80, Jun 2014. URL: https://doi.org/10.1186/1750-1172-9-80, doi:10.1186/1750-1172-9-80. This article has 21 citations and is from a peer-reviewed journal.

  2. (OpenTargets Search: -ZNF407): Open Targets Query (-ZNF407, 5 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.

  3. (kambouris2014mutationsinzinc pages 2-4): Marios Kambouris, Rachid C Maroun, Tawfeg Ben-Omran, Yasser Al-Sarraj, Khaoula Errafii, Rehab Ali, Hala Boulos, Patrick A Curmi, and Hatem El-Shanti. Mutations in zinc finger 407 [znf407] cause a unique autosomal recessive cognitive impairment syndrome. Orphanet Journal of Rare Diseases, 9:80-80, Jun 2014. URL: https://doi.org/10.1186/1750-1172-9-80, doi:10.1186/1750-1172-9-80. This article has 21 citations and is from a peer-reviewed journal.

  4. (kambouris2014mutationsinzinc pages 6-7): Marios Kambouris, Rachid C Maroun, Tawfeg Ben-Omran, Yasser Al-Sarraj, Khaoula Errafii, Rehab Ali, Hala Boulos, Patrick A Curmi, and Hatem El-Shanti. Mutations in zinc finger 407 [znf407] cause a unique autosomal recessive cognitive impairment syndrome. Orphanet Journal of Rare Diseases, 9:80-80, Jun 2014. URL: https://doi.org/10.1186/1750-1172-9-80, doi:10.1186/1750-1172-9-80. This article has 21 citations and is from a peer-reviewed journal.

  5. (kambouris2014mutationsinzinc pages 4-6): Marios Kambouris, Rachid C Maroun, Tawfeg Ben-Omran, Yasser Al-Sarraj, Khaoula Errafii, Rehab Ali, Hala Boulos, Patrick A Curmi, and Hatem El-Shanti. Mutations in zinc finger 407 [znf407] cause a unique autosomal recessive cognitive impairment syndrome. Orphanet Journal of Rare Diseases, 9:80-80, Jun 2014. URL: https://doi.org/10.1186/1750-1172-9-80, doi:10.1186/1750-1172-9-80. This article has 21 citations and is from a peer-reviewed journal.

  6. (charrier2024molecularregulationof pages 1-2): Alyssa Charrier, Jeremiah Ockunzzi, Leighanne Main, Siddharth V. Ghanta, and David A. Buchner. Molecular regulation of pparγ/rxrα signaling by the novel cofactor zfp407. PLOS ONE, 19:e0294003, May 2024. URL: https://doi.org/10.1371/journal.pone.0294003, doi:10.1371/journal.pone.0294003. This article has 5 citations and is from a peer-reviewed journal.

  7. (charrier2024molecularregulationof pages 2-4): Alyssa Charrier, Jeremiah Ockunzzi, Leighanne Main, Siddharth V. Ghanta, and David A. Buchner. Molecular regulation of pparγ/rxrα signaling by the novel cofactor zfp407. PLOS ONE, 19:e0294003, May 2024. URL: https://doi.org/10.1371/journal.pone.0294003, doi:10.1371/journal.pone.0294003. This article has 5 citations and is from a peer-reviewed journal.

  8. (charrier2024molecularregulationof pages 5-7): Alyssa Charrier, Jeremiah Ockunzzi, Leighanne Main, Siddharth V. Ghanta, and David A. Buchner. Molecular regulation of pparγ/rxrα signaling by the novel cofactor zfp407. PLOS ONE, 19:e0294003, May 2024. URL: https://doi.org/10.1371/journal.pone.0294003, doi:10.1371/journal.pone.0294003. This article has 5 citations and is from a peer-reviewed journal.

  9. (charrier2024molecularregulationof pages 4-5): Alyssa Charrier, Jeremiah Ockunzzi, Leighanne Main, Siddharth V. Ghanta, and David A. Buchner. Molecular regulation of pparγ/rxrα signaling by the novel cofactor zfp407. PLOS ONE, 19:e0294003, May 2024. URL: https://doi.org/10.1371/journal.pone.0294003, doi:10.1371/journal.pone.0294003. This article has 5 citations and is from a peer-reviewed journal.

Artifacts